,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,23,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
11,25,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
12,29,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
13,33,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
14,35,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
15,37,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
16,39,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
17,45,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
18,47,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
19,51,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
20,53,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
21,55,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
22,57,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
23,59,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
24,61,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
25,63,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
26,65,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
27,67,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
28,69,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
29,71,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
30,73,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
31,75,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
32,77,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
33,79,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
34,81,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
35,103,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
36,105,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
37,107,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
38,113,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
39,115,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
40,119,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
41,123,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
42,125,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
43,129,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
44,131,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
45,133,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
46,135,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
47,139,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
48,141,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
49,145,1,1,,477762,3220,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
50,155,1,1,,477762,3220,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
51,157,1,1,,477762,3220,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
52,161,1,1,,477762,3220,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
53,165,1,1,,477762,3220,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
54,167,1,1,,477762,3220,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
55,175,1,1,,477762,3220,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
56,179,1,1,,490979,3220,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
57,357,2,1,,11111157,3220,Inconclusive,,,,,AP1 Signaling Pathway,Confirmatory,,
58,382,1,4,,10318999,3220,Active,206729857.0,1195.0,,,"Compound Screen Assay, Human CLK1",Other,,
59,393,1,2,,10318999,3220,Active,4505811.0,5292.0,,,"Compound Screen Assay, Human PIM1",Other,,
60,410,1,5,,11111157,3220,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
61,410,1,5,,11111158,3220,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
62,411,2,1,,11111157,3220,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
63,411,2,1,,11111158,3220,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
64,421,1,3,,17389019,3220,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
65,422,1,5,,17405114,3220,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
66,426,1,2,,17389019,3220,Inconclusive,,,,,Cell Viability - Jurkat,Confirmatory,,
67,427,1,1,,17389019,3220,Inconclusive,,,,,Cell Viability - Hek293,Confirmatory,,
68,429,1,5,,17405114,3220,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
69,429,1,5,,17405114,3220,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
70,433,1,1,,17389019,3220,Inconclusive,,,,,Cell Viability - HepG2,Confirmatory,,
71,434,1,2,,17389019,3220,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
72,435,1,2,,17389019,3220,Active,,,,,Cell Viability - SK-N-SH,Confirmatory,,
73,436,2,1,,17405114,3220,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
74,444,1,1,,11111157,3220,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
75,445,3,1,,11111157,3220,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
76,445,3,1,,11111158,3220,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
77,445,3,1,,17389019,3220,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
78,446,1,1,,11111157,3220,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
79,447,1,1,,11111157,3220,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
80,447,1,1,,11111158,3220,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
81,448,1,2,,11111157,3220,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
82,448,1,2,,11111158,3220,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
83,450,1,2,,11111157,3220,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
84,450,1,2,,11111158,3220,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
85,451,1,2,,11111157,3220,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
86,451,1,2,,11111158,3220,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
87,505,1,2,,10318999,3220,Active,42821112.0,11040.0,,,"Compound Screen Assay, Human PIM2",Screening,,
88,526,1,1,,11111157,3220,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
89,526,1,1,,11111158,3220,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
90,530,1,1,,11111157,3220,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
91,530,1,1,,11111158,3220,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
92,530,1,1,,17389019,3220,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
93,540,1,1,,17389019,3220,Active,,,,,Cell Viability - N2a,Confirmatory,,
94,541,1,1,,17389019,3220,Inconclusive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
95,542,1,1,,17389019,3220,Active,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
96,543,1,1,,17389019,3220,Active,,,,,Cell Viability - H-4-II-E,Confirmatory,,
97,544,2,1,,17389019,3220,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
98,545,1,1,,17389019,3220,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
99,546,1,1,,17389019,3220,Inconclusive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
100,547,1,4,,17405114,3220,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
101,584,1,3,,11111157,3220,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
102,584,1,3,,11111158,3220,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
103,584,1,3,,17389019,3220,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
104,585,1,4,,11111157,3220,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
105,585,1,4,,11111158,3220,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
106,585,1,4,,17389019,3220,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
107,587,1,5,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
108,587,1,5,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
109,588,1,4,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
110,588,1,4,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
111,589,1,3,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
112,589,1,3,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
113,590,1,3,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
114,590,1,3,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
115,591,1,4,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
116,591,1,4,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
117,592,1,6,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
118,592,1,6,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
119,593,1,4,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
120,593,1,4,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
121,594,1,4,,11111157,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
122,594,1,4,,11111158,3220,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
123,595,1,3,,11111157,3220,Inconclusive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
124,595,1,3,,11111158,3220,Active,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
125,595,1,3,,17389019,3220,Inconclusive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
126,596,1,2,,11111157,3220,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
127,596,1,2,,11111158,3220,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
128,596,1,2,,17389019,3220,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
129,597,1,3,,11111157,3220,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
130,597,1,3,,11111158,3220,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
131,603,1,2,,11111157,3220,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
132,603,1,2,,11111158,3220,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
133,603,1,2,,17389019,3220,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
134,605,1,2,,11111157,3220,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
135,605,1,2,,11111158,3220,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
136,605,1,2,,17389019,3220,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
137,607,1,3,,11111157,3220,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
138,607,1,3,,11111158,3220,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
139,654,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
140,655,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
141,656,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
142,657,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
143,658,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
144,659,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
145,660,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
146,661,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
147,662,1,1,,11111157,3220,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
148,662,1,1,,11111158,3220,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
149,662,1,1,,17389019,3220,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
150,663,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
151,664,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
152,665,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
153,666,1,1,,17389019,3220,Inconclusive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
154,667,1,1,,17389019,3220,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
155,694,1,1,,17405114,3220,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
156,732,1,2,,17405114,3220,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
157,875,1,2,,17389019,3220,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
158,879,1,2,,17389019,3220,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
159,879,1,2,,17389019,3220,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
160,880,2,1,,17389019,3220,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
161,880,2,1,,17389019,3220,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
162,880,2,1,,50105616,3220,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
163,880,2,1,,50105616,3220,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
164,880,2,1,,50105617,3220,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
165,880,2,1,,50105617,3220,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
166,881,2,2,,17389019,3220,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
167,883,1,3,,11111157,3220,Active,13699818.0,1559.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
168,883,1,3,,11111158,3220,Active,13699818.0,1559.0,3.9811,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
169,884,1,2,,17389019,3220,Active,13435386.0,1576.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
170,885,1,2,,17389019,3220,Inactive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
171,886,1,2,,11111157,3220,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
172,886,1,2,,11111157,3220,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
173,886,1,2,,11111158,3220,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
174,886,1,2,,11111158,3220,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
175,886,1,2,,17389019,3220,Inconclusive,122921310.0,,0.3981,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
176,886,1,2,,17389019,3220,Inconclusive,122921311.0,,0.3981,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
177,887,1,2,,17389019,3220,Inconclusive,1832253.0,246.0,10.0,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
178,889,1,3,,17389019,3220,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
179,891,1,2,,11111157,3220,Active,40805836.0,1565.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
180,891,1,2,,11111158,3220,Active,40805836.0,1565.0,12.5893,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
181,892,1,2,,17389019,3220,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
182,893,1,2,,17389019,3220,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
183,893,1,2,,17389019,3220,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
184,894,2,1,,17389019,3220,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
185,894,2,1,,50105616,3220,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
186,894,2,1,,50105617,3220,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
187,895,1,2,,17389019,3220,Inconclusive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
188,899,1,2,,11111157,3220,Inconclusive,4503219.0,1557.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
189,899,1,2,,11111158,3220,Active,4503219.0,1557.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
190,900,1,3,,17389019,3220,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
191,901,1,2,,17389019,3220,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
192,902,1,2,,17389019,3220,Inactive,120407068.0,7157.0,31.6228,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
193,912,1,2,,11111157,3220,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
194,912,1,2,,11111158,3220,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
195,912,1,2,,17389019,3220,Inconclusive,21392848.0,,2.5119,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
196,914,1,3,,11111157,3220,Inconclusive,32879895.0,3091.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
197,915,1,3,,11111157,3220,Inconclusive,32879895.0,3091.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
198,917,1,3,,17389019,3220,Inconclusive,120660324.0,7066.0,12.5893,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
199,918,1,3,,17389019,3220,Active,120660324.0,7066.0,12.5893,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
200,921,1,2,,17389019,3220,Inconclusive,,,63.0957,Potency,Cell Viability - LYMP2-001,Confirmatory,,
201,923,1,2,,17389019,3220,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
202,924,1,2,,17389019,3220,Inactive,120407068.0,7157.0,31.6228,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
203,925,1,2,,11111157,3220,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
204,925,1,2,,17389019,3220,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
205,926,1,2,,11111157,3220,Inconclusive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
206,926,1,2,,11111158,3220,Inconclusive,38016895.0,7253.0,2.5119,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
207,926,1,2,,17389019,3220,Inconclusive,38016895.0,7253.0,7.9433,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
208,927,1,3,,17389019,3220,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
209,928,1,2,,17389019,3220,Inconclusive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
210,938,1,2,,11111157,3220,Inactive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
211,938,1,2,,11111158,3220,Inactive,38016895.0,7253.0,2.5119,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
212,938,1,2,,17389019,3220,Inactive,38016895.0,7253.0,7.9433,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
213,940,1,2,,17405114,3220,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
214,943,1,2,,17389019,3220,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
215,944,1,2,,17389019,3220,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
216,945,1,4,,17389019,3220,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
217,946,1,2,,17389019,3220,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
218,947,1,2,,17389019,3220,Inconclusive,,,0.631,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
219,948,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
220,954,1,2,,17389019,3220,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
221,955,1,2,,17389019,3220,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
222,957,1,2,,17389019,3220,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
223,958,1,2,,17389019,3220,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
224,959,1,4,,17389019,3220,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
225,960,1,2,,17389019,3220,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
226,961,1,2,,17389019,3220,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
227,962,1,2,,17389019,3220,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
228,963,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
229,964,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
230,965,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
231,966,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
232,967,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
233,968,1,2,,17389019,3220,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-009,Confirmatory,,
234,969,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
235,970,1,2,,17389019,3220,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-013,Confirmatory,,
236,971,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
237,972,1,2,,17389019,3220,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-017,Confirmatory,,
238,973,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-019,Confirmatory,,
239,974,1,2,,17389019,3220,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-021,Confirmatory,,
240,975,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-023,Confirmatory,,
241,976,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
242,977,1,2,,17389019,3220,Inconclusive,,,25.1189,Potency,Cell Viability - LYMP2-002,Confirmatory,,
243,978,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-006,Confirmatory,,
244,979,1,2,,17389019,3220,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-007,Confirmatory,,
245,980,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-008,Confirmatory,,
246,981,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-010,Confirmatory,,
247,982,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
248,983,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-014,Confirmatory,,
249,984,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
250,985,1,2,,17389019,3220,Inconclusive,,,25.1189,Potency,Cell Viability - LYMP2-018,Confirmatory,,
251,986,1,2,,17389019,3220,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-020,Confirmatory,,
252,987,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
253,988,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-024,Confirmatory,,
254,989,1,2,,17389019,3220,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-026,Confirmatory,,
255,992,1,3,,17389019,3220,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
256,993,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
257,994,1,2,,17389019,3220,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
258,995,1,2,,17389019,3220,Inconclusive,66932916.0,5594.0,12.5893,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
259,997,1,2,,17389019,3220,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
260,998,1,2,,17389019,3220,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
261,1030,2,1,,17389019,3220,Active,30582681.0,216.0,14.1254,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
262,1030,2,1,,50105616,3220,Active,30582681.0,216.0,12.5893,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
263,1030,2,1,,50105617,3220,Active,30582681.0,216.0,22.3872,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
264,1189,1,5,,48413713,3220,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
265,1194,1,3,,48413713,3220,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
266,1199,1,3,,48413713,3220,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
267,1205,1,4,,48413713,3220,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
268,1208,1,3,,48413713,3220,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
269,1376,1,2,,47193718,3220,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
270,1379,1,2,,50105616,3220,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
271,1379,1,2,,50105617,3220,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
272,1385,2,2,,47193718,3220,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
273,1422,1,1,,17405114,3220,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
274,1422,1,1,,47193718,3220,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
275,1452,1,1,,17389019,3220,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
276,1454,1,1,,50105616,3220,Inconclusive,66932916.0,5594.0,11.2202,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
277,1454,1,1,,50105617,3220,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
278,1457,1,1,,17389019,3220,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
279,1457,1,1,,50105616,3220,Inactive,44888968.0,83523.0,31.6228,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
280,1457,1,1,,50105617,3220,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
281,1458,1,1,,17389019,3220,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
282,1458,1,1,,50105616,3220,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
283,1459,1,1,,50105616,3220,Inactive,27436948.0,4000.0,,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
284,1460,1,3,,50105616,3220,Active,92096784.0,4137.0,8.9125,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
285,1460,1,3,,50105617,3220,Active,92096784.0,4137.0,10.0,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
286,1461,1,2,,50105616,3220,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
287,1463,1,1,,50105616,3220,Active,,,14.1254,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
288,1463,1,1,,50105617,3220,Active,,,15.8489,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
289,1465,1,1,,47193718,3220,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
290,1467,1,3,,50105616,3220,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
291,1467,1,3,,50105617,3220,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
292,1468,1,1,,50105616,3220,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
293,1468,1,1,,50105617,3220,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
294,1469,1,1,,17389019,3220,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
295,1469,1,1,,26753048,3220,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
296,1469,1,1,,50105616,3220,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
297,1469,1,1,,50105617,3220,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
298,1471,2,1,,11111157,3220,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
299,1471,2,1,,11111158,3220,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
300,1471,2,1,,17389019,3220,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
301,1471,2,1,,50105617,3220,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
302,1476,2,1,,17389019,3220,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
303,1476,2,1,,50105616,3220,Inconclusive,281307097.0,,3.1623,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
304,1476,2,1,,50105617,3220,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
305,1477,1,1,,17389019,3220,Inconclusive,,,12.5893,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
306,1477,1,1,,50105616,3220,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
307,1477,1,1,,50105617,3220,Inconclusive,,,14.1254,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
308,1478,2,1,,17389019,3220,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
309,1478,2,1,,50105616,3220,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
310,1478,2,1,,50105617,3220,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
311,1479,1,2,,17389019,3220,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
312,1479,1,2,,26753048,3220,Inconclusive,189491771.0,7068.0,112.20200000000001,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
313,1479,1,2,,50105616,3220,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
314,1479,1,2,,50105617,3220,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
315,1487,1,1,,50105616,3220,Inconclusive,27436948.0,4000.0,0.0056,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
316,1490,2,1,,50105617,3220,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
317,1511,1,3,,47193718,3220,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
318,1519,1,3,,50105616,3220,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
319,1519,1,3,,50105617,3220,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
320,1529,1,1,,47193718,3220,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
321,1530,1,1,,47193718,3220,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
322,1531,1,1,,47193718,3220,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
323,1532,1,1,,47193718,3220,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
324,1554,1,1,,47193718,3220,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
325,1621,1,2,,47193718,3220,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
326,1626,1,2,,47193718,3220,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
327,1662,1,2,,47193718,3220,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
328,1663,1,2,,47193718,3220,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
329,1672,1,3,,47193718,3220,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
330,1705,1,2,,50105616,3220,Active,6980812.0,,35.4813,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
331,1707,1,3,,50105616,3220,Active,,,28.1838,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
332,1708,1,3,,50105616,3220,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
333,1766,1,1,,50105616,3220,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
334,1766,1,1,,50105616,3220,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
335,1766,1,1,,50105617,3220,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
336,1766,1,1,,50105617,3220,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
337,1768,1,1,,50105616,3220,Inactive,18860839.0,4221.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
338,1768,1,1,,50105616,3220,Inactive,56550039.0,4297.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
339,1768,1,1,,50105617,3220,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
340,1768,1,1,,50105617,3220,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
341,1813,1,2,,47193718,3220,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
342,1814,1,2,,47193718,3220,Inconclusive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
343,1815,1,1,,50105616,3220,Active,,,11.2202,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
344,1816,1,1,,50105616,3220,Inconclusive,,,12.5893,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
345,1828,2,1,,50105616,3220,Inconclusive,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
346,1832,2,1,,47193718,3220,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
347,1850,2,1,,47193718,3220,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
348,1863,2,1,,47193718,3220,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
349,1865,1,1,,50105616,3220,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
350,1865,1,1,,50105617,3220,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
351,1875,2,1,,47193718,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
352,1876,1,1,,50105616,3220,Inconclusive,,,10.0,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
353,1877,1,1,,50105616,3220,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
354,1882,1,1,,50105616,3220,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
355,1883,1,1,,50105616,3220,Active,,,14.1254,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
356,1885,2,1,,47193718,3220,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
357,1886,1,1,,50105616,3220,Inconclusive,,,14.1254,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
358,1899,1,3,,47193718,3220,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
359,1903,2,3,,47193718,3220,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
360,1906,1,3,,47193718,3220,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
361,1910,1,2,,47193718,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
362,1947,1,2,,47193718,3220,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
363,1948,1,1,,17389019,3220,Inactive,,,6.3096,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
364,1948,1,1,,50105616,3220,Inactive,,,7.9433,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
365,1948,1,1,,50105617,3220,Inactive,,,5.0119,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
366,1950,1,3,,47193718,3220,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
367,1956,1,1,,47193718,3220,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
368,1962,1,2,,47193718,3220,Active,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
369,1967,1,1,,85231039,3220,Inconclusive,4505907.0,5376.0,,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
370,1974,1,2,,47193718,3220,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
371,1987,1,2,,47193718,3220,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
372,2016,1,3,,47193718,3220,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
373,2023,1,3,,47193718,3220,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
374,2025,1,3,,47193718,3220,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
375,2029,1,3,,47193718,3220,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
376,2052,2,1,,47193718,3220,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
377,2057,1,2,,47193718,3220,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
378,2066,1,4,,47193718,3220,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
379,2094,1,2,,47193718,3220,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
380,2094,1,2,,47193718,3220,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
381,2094,1,2,,47193718,3220,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
382,2097,1,2,,47193718,3220,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
383,2098,1,1,,47193718,3220,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
384,2099,1,1,,47193718,3220,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
385,2101,1,1,,17389019,3220,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
386,2101,1,1,,50105616,3220,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
387,2101,1,1,,50105617,3220,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
388,2107,1,1,,17389019,3220,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
389,2107,1,1,,50105616,3220,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
390,2107,1,1,,50105617,3220,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
391,2112,1,1,,17389019,3220,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
392,2112,1,1,,50105616,3220,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
393,2112,1,1,,50105617,3220,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
394,2120,1,1,,17389019,3220,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
395,2129,1,2,,47193718,3220,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
396,2130,1,3,,47193718,3220,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
397,2147,1,1,,50105616,3220,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
398,2147,1,1,,50105617,3220,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
399,2149,1,2,,47193718,3220,Active,68476498.0,,,,Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
400,2153,1,2,,47193718,3220,Active,83774548.0,5997907.0,,,Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1.,Screening,,
401,2156,2,2,,47193718,3220,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
402,2174,1,3,,47193718,3220,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
403,2177,1,3,,47193718,3220,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
404,2216,1,3,,47193718,3220,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
405,2221,1,2,,47193718,3220,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
406,2227,1,2,,47193718,3220,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
407,2234,1,2,,47193718,3220,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
408,2235,1,2,,47193718,3220,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
409,2237,1,2,,47193718,3220,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
410,2239,1,2,,47193718,3220,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
411,2240,1,1,,85789231,3220,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
412,2241,1,1,,85789231,3220,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
413,2247,1,2,,47193718,3220,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
414,2275,1,1,,85789231,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
415,2280,2,3,,47193718,3220,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
416,2300,1,3,,47193718,3220,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
417,2313,1,1,,85789231,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
418,2322,1,1,,85789231,3220,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
419,2323,1,1,,50105616,3220,Inconclusive,254220970.0,,39.8107,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
420,2326,1,1,,50105616,3220,Inactive,194352380.0,,12.5893,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
421,2330,1,1,,85789231,3220,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
422,2353,1,3,,50105616,3220,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
423,2364,1,2,,50105616,3220,Inconclusive,4557365.0,641.0,3.5481,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
424,2380,1,2,,47193718,3220,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
425,2391,1,1,,47193718,3220,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
426,2435,1,2,,47193718,3220,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
427,2445,1,2,,47193718,3220,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
428,2451,1,2,,50105616,3220,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
429,2451,1,2,,50105617,3220,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
430,2462,1,1,,47193718,3220,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
431,2462,1,1,,47193718,3220,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
432,2472,1,2,,50105617,3220,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
433,2517,2,1,,17389019,3220,Inconclusive,6980812.0,,35.4813,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
434,2517,2,1,,50105616,3220,Inconclusive,6980812.0,,10.0,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
435,2517,2,1,,50105617,3220,Inconclusive,6980812.0,,31.6228,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
436,2520,1,4,,47193718,3220,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
437,2521,1,3,,47193718,3220,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
438,2524,1,2,,47193718,3220,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
439,2528,1,2,,50105616,3220,Inconclusive,4557365.0,641.0,3.5481,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
440,2528,1,2,,50105617,3220,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
441,2540,1,2,,47193718,3220,Active,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
442,2544,1,2,,47193718,3220,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
443,2546,1,1,,17389019,3220,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
444,2546,1,1,,50105617,3220,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
445,2549,1,1,,17389019,3220,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
446,2549,1,1,,50105616,3220,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
447,2549,1,1,,50105617,3220,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
448,2550,1,3,,47193718,3220,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
449,2551,1,1,,17389019,3220,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
450,2551,1,1,,50105617,3220,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
451,2553,1,2,,47193718,3220,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
452,2557,1,3,,47193718,3220,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
453,2563,1,1,,47193718,3220,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
454,2599,1,2,,47193718,3220,Active,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
455,2606,1,2,,47193718,3220,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
456,2629,1,1,,47193718,3220,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
457,2642,1,2,,47193718,3220,Active,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
458,2648,1,2,,47193718,3220,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
459,2650,2,1,,47193718,3220,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
460,2660,1,1,,90340961,3220,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
461,2661,1,1,,47193718,3220,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
462,2662,2,1,,85231039,3220,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
463,2666,1,1,,90340961,3220,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
464,2667,1,1,,90340961,3220,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
465,2668,1,1,,90340961,3220,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
466,2675,1,1,,50105616,3220,Inconclusive,41281591.0,4154.0,15.8489,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
467,2690,1,2,,47193718,3220,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
468,2716,1,1,,47193718,3220,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
469,2717,1,2,,47193718,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
470,2718,1,1,,47193718,3220,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
471,2732,1,1,,17405114,3220,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
472,2751,2,2,,47193718,3220,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
473,2774,1,3,,92304038,3220,Inactive,,,,,LOPAC Circadian Assay,Screening,,
474,2796,1,4,,47193718,3220,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
475,2797,1,2,,47193718,3220,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
476,2805,2,2,,47193718,3220,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
477,2806,2,2,,47193718,3220,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
478,2825,1,2,,47193718,3220,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
479,19840,3,4,,103219982,3220,Unspecified,,,,,Partition coefficient of compound in octanol and water by Fragmental method of Leo/Hansch,Other,12639543.0,
480,37282,5,1,,103219982,3220,Inconclusive,,,,,Inhibitory activity against rat alpha-glucosidase; mild activity observed,Other,15203173.0,
481,37426,4,7,,103219982,3220,Inconclusive,,,,,Inhibitory activity against yeast alpha-glucosidase; mild activity observed,Other,15203173.0,
482,48230,3,7,,103219982,3220,Unspecified,,,,,Inhibitory activity against Cathepsin G (CatG) at 53 uM concentration,Other,1578486.0,
483,52618,3,7,,103219982,3220,Unspecified,,,,,Inhibitory activity against Chymotrypsinogen at 53 uM concentration,Other,1578486.0,
484,66485,9,2,,103219982,3220,Unspecified,,,52.0,IC50,Compound was tested for the enzyme inhibitory activity against Human Leukocyte Elastase (HLE) at 53 uM concentration,Confirmatory,1578486.0,
485,67314,3,7,,103219982,3220,Unspecified,,,,,Inhibitory activity against Human Leukocyte Elastase (HLE) at 53 uM concentration,Other,1578486.0,
486,67645,6,4,,103219982,3220,Inactive,,,,,Inhibitory activity against Porcine Pancreatic Elastase (PPE) at 53 uM concentration; NI = no inhibition,Other,1578486.0,
487,70335,9,2,,103219982,3220,Active,,,2.7,IC50,Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha,Confirmatory,11459643.0,
488,70353,9,2,,103219982,3220,Active,,,0.77,Ki,Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha,Confirmatory,11459643.0,
489,70654,9,2,,103219982,3220,Active,,,5.2,IC50,Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta,Confirmatory,11459643.0,
490,70660,9,2,,103219982,3220,Active,,,1.5,Ki,Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta,Confirmatory,11459643.0,
491,98690,8,1,,103219982,3220,Active,,,13.3,ID50,In vitro inhibition of L1210 mouse leukemia cell proliferation.,Confirmatory,3339601.0,
492,102409,4,8,,103219982,3220,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 1 uM,Other,11459643.0,
493,102410,4,8,,103219982,3220,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 10 uM,Other,11459643.0,
494,102411,4,8,,103219982,3220,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 3 uM,Other,11459643.0,
495,155387,8,7,,103219982,3220,Inconclusive,129614.0,110813108.0,,,Inhibitory activity against papain using HPLC assay; Not tested,Other,11720861.0,
496,163631,9,2,,103219982,3220,Unspecified,,,150.0,IC50,Inhibitory activity against HRV 3Cpro using HPLC assay,Confirmatory,11720861.0,
497,224308,8,4,,103219982,3220,Inconclusive,,,,,Inhibition of human purified recombinant pp60c-src tyrosine kinase,Other,10743952.0,
498,224313,3,8,,103219982,3220,Unspecified,,,,,Inhibition of human purified recombinant pp60c-src tyrosine kinase at 100 uM,Other,10743952.0,
499,247402,8,1,,103219982,3220,Active,,,10.0,GI50,Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program,Confirmatory,15743190.0,
500,260049,3,6,,103219982,3220,Inactive,,,,,Inhibitory activity on PDGF-induced ERK phosphorylation in NIH3T3 cells at 20 uM,Other,16275083.0,
501,260051,5,4,,103219982,3220,Inactive,,,,,Antiproliferative activity against human epidermal carcinoma A431 cell line at 20 uM by MTT method,Other,16275083.0,
502,260052,5,4,,103219982,3220,Inactive,,,,,Antiproliferative activity against prostate cancer PC3 cell line at 20 uM by MTT method,Other,16275083.0,
503,260053,3,3,,103219982,3220,Unspecified,,,,,Antifungal activity against Fusarium oxysporum at 0.5 mg/ml,Other,16275083.0,
504,260054,3,3,,103219982,3220,Unspecified,,,,,Antifungal activity against Gibberella zeae at 0.5 mg/ml,Other,16275083.0,
505,260055,3,3,,103219982,3220,Unspecified,,,,,Antifungal activity against Phytopthora infestans at 0.5 mg/ml,Other,16275083.0,
506,285171,6,2,,103219982,3220,Unspecified,,,,,Activity against planktonic Streptococcus mutans LMG 14558,Other,17220400.0,
507,285172,3,3,,103219982,3220,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 5 ug/ml relative to BHIS control,Other,17220400.0,
508,285173,3,3,,103219982,3220,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 2 ug/ml relative to BHIS control,Other,17220400.0,
509,285174,3,3,,103219982,3220,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 1 ug/ml relative to BHIS control,Other,17220400.0,
510,285175,3,3,,103219982,3220,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 0.5 ug/ml relative to BHIS control,Other,17220400.0,
511,285176,3,3,,103219982,3220,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 0.1 ug/ml relative to BHIS control relative to BHIS control,Other,17220400.0,
512,285180,3,3,,103219982,3220,Inactive,,,,,Susceptibility of Streptococcus mutans LMG 14558 in BHIS medium assessed as increase in biofilm formation at 5 ug/ml in presence of 0.025% cysteine,Other,17220400.0,
513,285181,3,3,,103219982,3220,Unspecified,,,,,Decrease in membrane fluidity of Streptococcus mutans LMG 14558 using pyrene in BHI medium at 5 ug/ml relative to BHI control,Other,17220400.0,
514,285182,4,3,,103219982,3220,Unspecified,,,,,Effect on membrane fluidity of DPH-labeled Streptococcus mutans LMG 14558 in BHI medium assessed as fluorescence anisotropy at 5 ug/ml relative to BHI control,Other,17220400.0,
515,295725,6,4,,103219982,3220,Active,,,6.8,Ki,Binding affinity to calf thymus DNA,Confirmatory,17408812.0,
516,295726,6,2,,103219982,3220,Unspecified,,,100.0,IC50,Cytotoxicity against mouse B16 cells,Confirmatory,17408812.0,
517,295727,6,2,,103219982,3220,Unspecified,,,55.1,IC50,Cytotoxicity against human HepG2 cells,Confirmatory,17408812.0,
518,295728,6,3,,103219982,3220,Unspecified,,,100.0,IC50,Cytotoxicity against mouse LLC cells,Confirmatory,17408812.0,
519,328646,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Staphylococcus aureus ssp. Aureus DSM 799 by disk diffusion method,Other,18220354.0,
520,328647,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Klebsiella pneumoniae ssp. ozaenae DSM 681 by disk diffusion method,Other,18220354.0,
521,328648,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Pseudomonas aeruginosa DSM 1128 by disk diffusion method,Other,18220354.0,
522,328649,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Salmonella enterica ssp. enterica DSM 9898 by disk diffusion method,Other,18220354.0,
523,328650,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Escherichia coli DSM 682 by disk diffusion method,Other,18220354.0,
524,328651,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Aspergillus niger DSM 1988 by disk diffusion method,Other,18220354.0,
525,328652,3,3,,103219982,3220,Active,,,,,Antimicrobial activity against Candida albicans DSM 1386 by disk diffusion method,Other,18220354.0,
526,335386,6,3,,103219982,3220,Unspecified,,,,,Inhibition of bovine thymus p56 LCK activity,Other,1517743.0,
527,335387,6,3,,103219982,3220,Active,,,13.0,Ki,Inhibition of bovine thymus p56 LCK activity by competitive inhibition assay,Confirmatory,1517743.0,
528,335388,3,4,,103219982,3220,Active,,,,,Inhibition of bovine thymus p56 LCK activity by noncompetitive inhibition assay,Other,1517743.0,
529,335922,6,1,,103219982,3220,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of arachidonic acid-stimulated platelet aggregation pretreated 2 mins before arachidonic acid challenge,Other,2213033.0,
530,335923,6,1,,103219982,3220,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of ADP-stimulated platelet aggregation pretreated 2 mins before ADP challenge,Other,2213033.0,
531,335924,6,1,,103219982,3220,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of collagen-stimulated platelet aggregation pretreated 2 mins before collagen challenge,Other,2213033.0,
532,336034,11,1,,103219982,3220,Unspecified,,,,,Inhibition of bovine thymus p56LCK,Other,8277318.0,
533,336287,5,1,,103219982,3220,Unspecified,,,,,Cytotoxicity against human PLC/PRF/5 cells,Other,,
534,336288,5,1,,103219982,3220,Unspecified,,,,,Cytotoxicity against human KB cells,Other,,
535,336953,3,5,,103219982,3220,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA,Other,2558164.0,
536,336954,3,5,,103219982,3220,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA,Other,2558164.0,
537,336955,3,5,,103219982,3220,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA,Other,2558164.0,
538,336956,3,5,,103219982,3220,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA,Other,2558164.0,
539,336957,3,5,,103219982,3220,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio,Other,2558164.0,
540,336958,3,5,,103219982,3220,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio,Other,2558164.0,
541,336959,3,5,,103219982,3220,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio,Other,2558164.0,
542,336960,3,5,,103219982,3220,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio,Other,2558164.0,
543,338266,3,4,,103219982,3220,Inactive,,,,,Inhibition of Ca2+ ATPase activity in human red blood cells at 1600 uM by spectrophotometry,Other,7714535.0,
544,339127,3,4,,103219982,3220,Unspecified,,,,,Inhibition of ADP-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
545,339128,3,4,,103219982,3220,Unspecified,,,,,Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
546,339129,3,4,,103219982,3220,Unspecified,,,,,Inhibition of collagen-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
547,339130,3,4,,103219982,3220,Unspecified,,,,,Inhibition of platelet activity factor-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
548,339132,3,4,,103219982,3220,Unspecified,,,,,Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 50 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
549,339133,3,4,,103219982,3220,Unspecified,,,,,Inhibition of collagen-induced platelet aggregation in rabbit platelet-rich plasma at 50 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
550,339136,3,4,,103219982,3220,Unspecified,,,,,Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 25 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
551,339150,11,1,,103219982,3220,Unspecified,,,,,Inhibition of bovine thymus p56-LCK protein tyrosine kinase activity,Other,8350096.0,
552,343958,3,4,,103219982,3220,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells at 1000 molar ratio relative to control,Other,18556196.0,
553,343959,3,4,,103219982,3220,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells at 500 molar ratio relative to control,Other,18556196.0,
554,343960,3,4,,103219982,3220,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells at 100 molar ratio relative to control,Other,18556196.0,
555,343961,3,4,,103219982,3220,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells at 10 molar ratio relative to control,Other,18556196.0,
556,343962,3,5,,103219982,3220,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells,Other,18556196.0,
557,343963,3,4,,103219982,3220,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio,Other,18556196.0,
558,352795,9,5,,103219982,3220,Active,55977123.0,1457.0,2.0,IC50,Inhibition of GST-fused human recombinant CK2alpha expressed in Escherichia coli HMS174 (DE3),Confirmatory,19414254.0,
559,355620,3,6,,103219982,3220,Unspecified,,,,,In vivo cytotoxicity against mouse P388 cells relative to control,Other,2778455.0,
560,355621,6,3,,103219982,3220,Unspecified,,,,,Toxicity in brine shrimp,Other,2778455.0,
561,355622,5,4,,103219982,3220,Unspecified,,,,,Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumors in potato tubers by potato disk test,Other,2778455.0,
562,355623,5,1,,103219982,3220,Unspecified,,,,,Cytotoxicity against human A549 cells,Other,2778455.0,
563,355624,5,1,,103219982,3220,Unspecified,,,,,Cytotoxicity against human HT-29 cells,Other,2778455.0,
564,355625,5,1,,103219982,3220,Unspecified,,,,,Cytotoxicity against human KBMRI cells,Other,2778455.0,
565,356320,6,3,,103219982,3220,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,12932135.0,
566,357642,6,2,,103219982,3220,Inactive,,,,IC50,Cytotoxicity against human KB cells,Confirmatory,11575949.0,
567,358174,14,1,,103219982,3220,Unspecified,,,,IC50,Inhibition of p56 lck,Confirmatory,1479375.0,
568,358185,7,3,,103219982,3220,Active,,,,IC50,Cytotoxicity against human CCRF-CEM cells,Confirmatory,1479375.0,
569,358186,7,5,,103219982,3220,Unspecified,,,,IC50,Cytotoxicity against human HL-60(TB) cells,Confirmatory,1479375.0,
570,358188,7,3,,103219982,3220,Active,,,,IC50,Cytotoxicity against human MOLT4 cells,Confirmatory,1479375.0,
571,358189,7,4,,103219982,3220,Unspecified,,,,IC50,Cytotoxicity against human RPMI8226 cells,Confirmatory,1479375.0,
572,358190,7,3,,103219982,3220,Active,,,,IC50,Cytotoxicity against human SR cells,Confirmatory,1479375.0,
573,358191,5,3,,103219982,3220,Active,,,26.9153,GI50,Cytotoxicity against human A549 cells,Confirmatory,1479375.0,
574,358192,5,4,,103219982,3220,Unspecified,,,,GI50,Cytotoxicity against human HOP18 cells,Confirmatory,1479375.0,
575,358193,5,3,,103219982,3220,Active,,,8.12831,GI50,Cytotoxicity against human HOP62 cells,Confirmatory,1479375.0,
576,358194,5,3,,103219982,3220,Active,,,11.4815,GI50,Cytotoxicity against human HOP92 cells,Confirmatory,1479375.0,
577,358195,5,3,,103219982,3220,Active,,,33.1131,GI50,Cytotoxicity against human NCI-H226 cells,Confirmatory,1479375.0,
578,358196,5,3,,103219982,3220,Active,,,14.4544,GI50,Cytotoxicity against human NCI-H23 cells,Confirmatory,1479375.0,
579,358197,5,3,,103219982,3220,Active,,,35.4813,GI50,Cytotoxicity against human NCI-H322M cells,Confirmatory,1479375.0,
580,358198,5,3,,103219982,3220,Active,,,19.9526,GI50,Cytotoxicity against human NCI-H460 cells,Confirmatory,1479375.0,
581,358199,5,3,,103219982,3220,Active,,,14.4544,GI50,Cytotoxicity against human NCI-H522 cells,Confirmatory,1479375.0,
582,358200,5,4,,103219982,3220,Active,,,24.5471,GI50,Cytotoxicity against human LXFL 529L cells,Confirmatory,1479375.0,
583,358201,5,4,,103219982,3220,Unspecified,,,,GI50,Cytotoxicity against human DMS114 cells,Confirmatory,1479375.0,
584,358202,5,4,,103219982,3220,Unspecified,,,,GI50,Cytotoxicity against human DMS273 cells,Confirmatory,1479375.0,
585,358203,5,3,,103219982,3220,Active,,,17.7828,GI50,Cytotoxicity against human COLO205 cells,Confirmatory,1479375.0,
586,358204,5,3,,103219982,3220,Active,,,23.4423,GI50,Cytotoxicity against human DLD1 cells,Confirmatory,1479375.0,
587,358205,5,3,,103219982,3220,Active,,,32.3594,GI50,Cytotoxicity against human HCC2998 cells,Confirmatory,1479375.0,
588,358206,5,3,,103219982,3220,Active,,,36.3078,GI50,Cytotoxicity against human HCT116 cells,Confirmatory,1479375.0,
589,358207,5,3,,103219982,3220,Active,,,26.9153,GI50,Cytotoxicity against human HCT15 cells,Confirmatory,1479375.0,
590,358208,5,3,,103219982,3220,Active,,,31.6228,GI50,Cytotoxicity against human HT-29 cells,Confirmatory,1479375.0,
591,358209,5,3,,103219982,3220,Active,,,26.3027,GI50,Cytotoxicity against human KM12 cells,Confirmatory,1479375.0,
592,358210,5,4,,103219982,3220,Unspecified,,,,GI50,Cytotoxicity against human KM20L2 cells,Confirmatory,1479375.0,
593,358211,5,3,,103219982,3220,Active,,,23.4423,GI50,Cytotoxicity against human SW620 cells,Confirmatory,1479375.0,
594,358212,5,3,,103219982,3220,Active,,,25.704,GI50,Cytotoxicity against human SF268 cells,Confirmatory,1479375.0,
595,358213,5,3,,103219982,3220,Active,,,28.1838,GI50,Cytotoxicity against human SF295 cells,Confirmatory,1479375.0,
596,358214,5,3,,103219982,3220,Active,,,30.1995,GI50,Cytotoxicity against human SNB19 cells,Confirmatory,1479375.0,
597,358215,5,3,,103219982,3220,Active,,,25.704,GI50,Cytotoxicity against human SNB75 cells,Confirmatory,1479375.0,
598,358216,5,3,,103219982,3220,Active,,,27.5423,GI50,Cytotoxicity against human U251 cells,Confirmatory,1479375.0,
599,358217,5,3,,103219982,3220,Active,,,26.3027,GI50,Cytotoxicity against human XF498 cells,Confirmatory,1479375.0,
600,358474,5,3,,103219982,3220,Active,,,16.9824,GI50,Cytotoxicity against human LOXIMVI cells,Confirmatory,1479375.0,
601,358475,5,3,,103219982,3220,Active,,,11.749,GI50,Cytotoxicity against human MALME-3M cells,Confirmatory,1479375.0,
602,358476,5,3,,103219982,3220,Active,,,25.1189,GI50,Cytotoxicity against human M14 cells,Confirmatory,1479375.0,
603,358477,5,3,,103219982,3220,Active,,,20.4174,GI50,Cytotoxicity against human SK-MEL-2 cells,Confirmatory,1479375.0,
604,358478,5,3,,103219982,3220,Active,,,36.3078,GI50,Cytotoxicity against human SK-MEL-28 cells,Confirmatory,1479375.0,
605,358479,5,3,,103219982,3220,Active,,,2.63027,GI50,Cytotoxicity against human SK-MEL-5 cells,Confirmatory,1479375.0,
606,358480,5,3,,103219982,3220,Active,,,28.1838,GI50,Cytotoxicity against human UACC257 cells,Confirmatory,1479375.0,
607,358481,5,3,,103219982,3220,Active,,,30.1995,GI50,Cytotoxicity against human OVCAR4 cells,Confirmatory,1479375.0,
608,358482,5,3,,103219982,3220,Active,,,38.0189,GI50,Cytotoxicity against human OVCAR5 cells,Confirmatory,1479375.0,
609,358483,5,3,,103219982,3220,Active,,,23.4423,GI50,Cytotoxicity against human SKOV3 cells,Confirmatory,1479375.0,
610,358484,5,4,,103219982,3220,Active,,,17.378,GI50,Cytotoxicity against human 786-O cells,Confirmatory,1479375.0,
611,358485,5,3,,103219982,3220,Active,,,16.5959,GI50,Cytotoxicity against human A498 cells,Confirmatory,1479375.0,
612,358486,5,3,,103219982,3220,Active,,,19.0546,GI50,Cytotoxicity against human ACHN cells,Confirmatory,1479375.0,
613,358487,5,3,,103219982,3220,Active,,,45.7088,GI50,Cytotoxicity against human Caki1 cells,Confirmatory,1479375.0,
614,358488,5,4,,103219982,3220,Unspecified,,,,GI50,Cytotoxicity against human RXF393 cells,Confirmatory,1479375.0,
615,358489,5,4,,103219982,3220,Active,,,22.3872,GI50,Cytotoxicity against human RXF631 cells,Confirmatory,1479375.0,
616,358490,5,3,,103219982,3220,Unspecified,,,67.6083,GI50,Cytotoxicity against human SN12C cells,Confirmatory,1479375.0,
617,358491,5,3,,103219982,3220,Active,,,23.4423,GI50,Cytotoxicity against human TK10 cells,Confirmatory,1479375.0,
618,358495,5,4,,103219982,3220,Unspecified,,,,GI50,Cytotoxicity against human SNB78 cells,Confirmatory,1479375.0,
619,360613,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Calu1 cells assessed as [3H]thymidine incorporation at 100 uM after 3 days by scintillation counting,Other,11374975.0,
620,360614,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Calu1 cells assessed as [3H]thymidine incorporation at 50 uM after 3 days by scintillation counting,Other,11374975.0,
621,360615,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Calu1 cells assessed as [3H]thymidine incorporation at 25 uM after 3 days by scintillation counting,Other,11374975.0,
622,360616,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Calu1 cells assessed as [3H]thymidine incorporation at 12.5 uM after 3 days by scintillation counting,Other,11374975.0,
623,360617,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Calu1 cells assessed as [3H]thymidine incorporation at 6.25 uM after 3 days by scintillation counting,Other,11374975.0,
624,360618,6,3,,103219982,3220,Active,,,6.25,IC50,Inhibition of human Calu1 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
625,360620,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human HeLa cells assessed as [3H]thymidine incorporation at 100 uM after 3 days by scintillation counting,Other,11374975.0,
626,360621,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human HeLa cells assessed as [3H]thymidine incorporation at 50 uM after 3 days by scintillation counting,Other,11374975.0,
627,360622,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human HeLa cells assessed as [3H]thymidine incorporation at 25 uM after 3 days by scintillation counting,Other,11374975.0,
628,360623,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human HeLa cells assessed as [3H]thymidine incorporation at 12.5 uM after 3 days by scintillation counting,Other,11374975.0,
629,360624,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human HeLa cells assessed as [3H]thymidine incorporation at 6.25 uM after 3 days by scintillation counting,Other,11374975.0,
630,360626,6,2,,103219982,3220,Active,,,15.6,IC50,Inhibition of human HeLa cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
631,360627,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human K562 cells assessed as [3H]thymidine incorporation at 100 uM after 3 days by scintillation counting,Other,11374975.0,
632,360628,4,4,,103219982,3220,Inconclusive,,,,,Growth inhibition of human K562 cells assessed as [3H]thymidine incorporation at 50 uM after 3 days by scintillation counting,Other,11374975.0,
633,360629,4,4,,103219982,3220,Inconclusive,,,,,Growth inhibition of human K562 cells assessed as [3H]thymidine incorporation at 25 uM after 3 days by scintillation counting,Other,11374975.0,
634,360630,4,4,,103219982,3220,Inconclusive,,,,,Growth inhibition of human K562 cells assessed as [3H]thymidine incorporation at 12.5 uM after 3 days by scintillation counting,Other,11374975.0,
635,360631,4,4,,103219982,3220,Inconclusive,,,,,Growth inhibition of human K562 cells assessed as [3H]thymidine incorporation at 6.25 uM after 3 days by scintillation counting,Other,11374975.0,
636,360633,6,2,,103219982,3220,Unspecified,,,100.0,IC50,Inhibition of human K562 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
637,360634,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Raji cells assessed as [3H]thymidine incorporation at 100 uM after 3 days by scintillation counting,Other,11374975.0,
638,360635,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Raji cells assessed as [3H]thymidine incorporation at 50 uM after 3 days by scintillation counting,Other,11374975.0,
639,360636,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Raji cells assessed as [3H]thymidine incorporation at 25 uM after 3 days by scintillation counting,Other,11374975.0,
640,360637,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Raji cells assessed as [3H]thymidine incorporation at 12.5 uM after 3 days by scintillation counting,Other,11374975.0,
641,360638,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human Raji cells assessed as [3H]thymidine incorporation at 6.25 uM after 3 days by scintillation counting,Other,11374975.0,
642,360640,6,2,,103219982,3220,Active,,,43.8,IC50,Inhibition of human Raji cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
643,360641,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of african green monkey Vero cells assessed as [3H]thymidine incorporation at 100 uM after 3 days by scintillation counting,Other,11374975.0,
644,360642,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of african green monkey Vero cells assessed as [3H]thymidine incorporation at 50 uM after 3 days by scintillation counting,Other,11374975.0,
645,360643,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of african green monkey Vero cells assessed as [3H]thymidine incorporation at 25 uM after 3 days by scintillation counting,Other,11374975.0,
646,360644,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of african green monkey Vero cells assessed as [3H]thymidine incorporation at 12.5 uM after 3 days by scintillation counting,Other,11374975.0,
647,360645,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of african green monkey Vero cells assessed as [3H]thymidine incorporation at 6.25 uM after 3 days by scintillation counting,Other,11374975.0,
648,360647,6,2,,103219982,3220,Active,,,40.0,IC50,Inhibition of african green monkey Vero cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
649,360648,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human WISH cells assessed as [3H]thymidine incorporation at 100 uM after 3 days by scintillation counting,Other,11374975.0,
650,360649,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human WISH cells assessed as [3H]thymidine incorporation at 50 uM after 3 days by scintillation counting,Other,11374975.0,
651,360650,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human WISH cells assessed as [3H]thymidine incorporation at 25 uM after 3 days by scintillation counting,Other,11374975.0,
652,360651,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human WISH cells assessed as [3H]thymidine incorporation at 12.5 uM after 3 days by scintillation counting,Other,11374975.0,
653,360652,3,4,,103219982,3220,Unspecified,,,,,Growth inhibition of human WISH cells assessed as [3H]thymidine incorporation at 6.25 uM after 3 days by scintillation counting,Other,11374975.0,
654,360654,6,2,,103219982,3220,Active,,,28.8,IC50,Inhibition of human WISH cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting,Confirmatory,11374975.0,
655,363328,6,2,,103219982,3220,Active,,,5.7,IC50,Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay,Confirmatory,17949858.0,
656,363329,6,2,,103219982,3220,Active,,,5.2,IC50,Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay,Confirmatory,17949858.0,
657,375433,9,5,,103219982,3220,Unspecified,21263835.0,64805.0,10.0,Ki,Displacement of [3H]PSB0413 from human platelet P2Y12 receptor,Confirmatory,19463000.0,
658,375434,4,7,,103219982,3220,Unspecified,21263835.0,64805.0,,,Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM,Other,19463000.0,
659,380384,10,1,,103219982,3220,Unspecified,,,130.0,IC50,Phytotoxicity against Amaranthus hypochondriacus assessed as inhibition of radicle elongation,Confirmatory,10869195.0,
660,380385,10,1,,103219982,3220,Active,,,20.0,IC50,Phytotoxicity against Echinochloa crusgalli assessed as inhibition of radicle elongation,Confirmatory,10869195.0,
661,380386,3,9,,103219982,3220,Active,49037473.0,326597.0,,,Binding affinity to bovine brain calmodulin at 0.033 ug/mL after 1.5 hrs by electrophoretic mobility assay in presence of calcium chloride,Other,10869195.0,
662,380387,3,9,,103219982,3220,Inactive,49037473.0,326597.0,,,Binding affinity to bovine brain calmodulin at 0.033 ug/mL after 1.5 hrs by electrophoretic mobility assay in presence of EGTA,Other,10869195.0,
663,380388,3,9,,103219982,3220,Active,122063217.0,,,,Binding affinity to spinach calmodulin at 0.033 ug/mL after 1.5 hrs by electrophoretic mobility assay in presence of calcium chloride,Other,10869195.0,
664,380389,3,9,,103219982,3220,Active,122063217.0,,,,Binding affinity to spinach calmodulin at 0.033 ug/mL after 1.5 hrs by electrophoretic mobility assay presence of EGTA,Other,10869195.0,
665,398696,6,4,,103219982,3220,Active,,,12.5,IC50,Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced oxygen consumption,Confirmatory,7494143.0,
666,398697,6,4,,103219982,3220,Active,,,16.8,IC50,Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation,Confirmatory,7494143.0,
667,398700,3,5,,103219982,3220,Inactive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 90 mins,Other,7494143.0,
668,398701,3,5,,103219982,3220,Inactive,,,,,Antioxidant activity in Sprague-Dawley rat heart mitochondria assessed as inhibition of conjugated diene formation at 1 to 300 uM,Other,7494143.0,
669,423618,4,4,,103219982,3220,Unspecified,,,,,Cytotoxicity against mouse L5178Y cells at 10 ug/mL by MTT assay,Other,19271717.0,
670,434955,1,2,,47193718,3220,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
671,434959,1,1,,85789231,3220,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
672,434962,1,2,,47193718,3220,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
673,434973,1,3,,47193718,3220,Active,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
674,434989,1,1,,47193718,3220,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
675,435003,1,3,,47193718,3220,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
676,435005,1,1,,47193718,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
677,435019,1,1,,47193718,3220,Active,,,20.079,CC50,A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis,Confirmatory,,
678,435022,2,2,,47193718,3220,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
679,435030,1,2,,47193718,3220,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
680,435030,1,2,,47193718,3220,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
681,435140,3,5,,103219982,3220,Unspecified,,,,,Relative inhibition of I174A-mutated CK2 holoenzyme compared to wild-type,Other,12816539.0,
682,435141,3,8,,103219982,3220,Unspecified,,,,,Percent residual p38-gamma activity in the presence of 10uM inhibitor,Other,12816539.0,
683,435142,3,7,,103219982,3220,Unspecified,,,,,Percent residual p38delta activity in the presence of 10uM inhibitor,Other,12816539.0,
684,435143,3,7,,103219982,3220,Unspecified,,,,,Percent residual SGK activity in the presence of 10uM inhibitor,Other,12816539.0,
685,435144,3,7,,103219982,3220,Unspecified,,,,,Percent residual S6K1 activity in the presence of 10uM inhibitor,Other,12816539.0,
686,435268,3,7,,103219982,3220,Unspecified,,,,,Percent residual p38alpha activity in the presence of 10uM inhibitor,Other,12816539.0,
687,435269,3,7,,103219982,3220,Unspecified,,,,,Percent residual AMPK activity in the presence of 10uM inhibitor,Other,12816539.0,
688,435270,3,8,,103219982,3220,Unspecified,,,,,Percent residual CDK2-cyclinA activity in the presence of 10uM inhibitor,Other,12816539.0,
689,435271,3,9,,103219982,3220,Unspecified,1723770.0,853178.0,,,Percent residual PiD261 activity in the presence of 10uM inhibitor,Other,12816539.0,
690,435272,3,7,,103219982,3220,Unspecified,,,,,Percent residual Syk activity in the presence of 10uM inhibitor,Other,12816539.0,
691,435389,3,7,,103219982,3220,Unspecified,,,,,Percent residual ERK2 activity in the presence of 10uM inhibitor,Other,12816539.0,
692,435390,3,7,,103219982,3220,Unspecified,,,,,Percent residual PKA activity in the presence of 10uM inhibitor,Other,12816539.0,
693,435391,3,7,,103219982,3220,Unspecified,,,,,Percent residual PDK1 activity in the presence of 10uM inhibitor,Other,12816539.0,
694,435510,3,7,,103219982,3220,Unspecified,,,,,Percent residual ROCK-II activity in the presence of 10uM inhibitor,Other,12816539.0,
695,435511,3,7,,103219982,3220,Unspecified,,,,,Percent residual CK2 activity in the presence of 10uM inhibitor,Other,12816539.0,
696,435549,3,7,,103219982,3220,Unspecified,,,,,Percent residual MAPKAPK2 activity in the presence of 10uM inhibitor,Other,12816539.0,
697,435639,8,2,,103219982,3220,Active,,,0.89,IC50,Inhibition of Zea mays CK2alpha,Confirmatory,12816539.0,
698,435640,7,2,,103219982,3220,Active,,,0.89,IC50,Inhibition of wild-type CK2 holoenzyme,Confirmatory,12816539.0,
699,435641,3,8,,103219982,3220,Unspecified,,,,,Percent residual GSK3-beta activity in the presence of 10uM inhibitor,Other,12816539.0,
700,435684,3,5,,103219982,3220,Unspecified,,,,,Percent residual Phosphorylase kinase activity in the presence of 10uM inhibitor,Other,12816539.0,
701,435685,3,7,,103219982,3220,Unspecified,,,,,Percent residual c-Fgr activity in the presence of 10uM inhibitor,Other,12816539.0,
702,435763,8,2,,103219982,3220,Active,,,1.85,Ki,Inhibitory constant against Zea mays CK2alpha,Confirmatory,12816539.0,
703,435764,7,2,,103219982,3220,Active,,,38.0,IC50,Inhibition of V66A-mutated CK2 holoenzyme,Confirmatory,12816539.0,
704,435765,3,7,,103219982,3220,Unspecified,,,,,Percent residual p38beta activity in the presence of 10uM inhibitor,Other,12816539.0,
705,435766,3,7,,103219982,3220,Unspecified,,,,,Percent residual MAPKAPK1 activity in the presence of 10uM inhibitor,Other,12816539.0,
706,435767,3,7,,103219982,3220,Unspecified,,,,,Percent residual PRAK activity in the presence of 10uM inhibitor,Other,12816539.0,
707,435768,3,7,,103219982,3220,Unspecified,,,,,Percent residual G-CK activity in the presence of 10uM inhibitor,Other,12816539.0,
708,435769,3,7,,103219982,3220,Unspecified,,,,,Percent residual Lck activity in the presence of 10uM inhibitor,Other,12816539.0,
709,435770,3,7,,103219982,3220,Unspecified,,,,,Percent residual CSK activity in the presence of 10uM inhibitor,Other,12816539.0,
710,435887,8,2,,103219982,3220,Unspecified,,,40.0,Ki,Inhibitory constant against maize casein kinase 2,Confirmatory,12419810.0,
711,435888,3,5,,103219982,3220,Unspecified,,,,,Relative inhibition of V66A-mutated CK2 holoenzyme compared to wild-type,Other,12816539.0,
712,435889,3,7,,103219982,3220,Unspecified,,,,,Percent residual MKK1 activity in presence of 10uM inhibitor,Other,12816539.0,
713,435890,3,7,,103219982,3220,Unspecified,,,,,Percent residual MSK1 activity in the presence of 10uM inhibitor,Other,12816539.0,
714,435891,3,7,,103219982,3220,Unspecified,,,,,Percent residual PKCalpha activity in the presence of 10uM inhibitor,Other,12816539.0,
715,435892,3,7,,103219982,3220,Unspecified,,,,,Percent residual CHK1 activity in the presence of 10uM inhibitor,Other,12816539.0,
716,435893,3,8,,103219982,3220,Unspecified,,,,,Percent residual CK1 activity in the presence of 10uM inhibitor,Other,12816539.0,
717,435894,3,7,,103219982,3220,Unspecified,,,,,Percent residual Lyn activity in the presence of 10uM inhibitor,Other,12816539.0,
718,436001,3,7,,103219982,3220,Unspecified,,,,,Percent residual DYRK1a activity in the presence of 10uM inhibitor,Other,12816539.0,
719,436039,7,2,,103219982,3220,Active,,,7.3,IC50,Inhibition of I174A-mutated CK2 holoenzyme,Confirmatory,12816539.0,
720,436040,3,7,,103219982,3220,Unspecified,,,,,Percent residual JNK activity in the presence of 10uM inhibitor,Other,12816539.0,
721,436041,3,8,,103219982,3220,Unspecified,,,,,Percent residual PKBalpha activity in the presence of 10uM inhibitor,Other,12816539.0,
722,449728,1,2,,47193718,3220,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
723,449739,1,2,,47193718,3220,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
724,449762,1,2,,47193718,3220,Active,,,91.52,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
725,449763,1,3,,47193718,3220,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
726,449764,1,1,,47193718,3220,Active,,,88.95,IC50,A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol,Confirmatory,,
727,449768,1,1,,47193718,3220,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
728,458596,5,2,,103219982,3220,Active,,,30.7,CC50,Cytotoxicity against human A549 cells after 48 hrs,Confirmatory,20108931.0,
729,458599,5,2,,103219982,3220,Active,,,10.9,EC50,Antiviral activity against Dengue virus type 2 infected in human A549 cells assessed as decrease in viral E protein production by cell-based flavivirus immunodetection assay,Confirmatory,20108931.0,
730,458603,5,2,,103219982,3220,Unspecified,,,79.8,IC50,Inhibition of Dengue virus type 2 NS5 RNA methyltransferase SAM site with 0.1 % TX100,Confirmatory,20108931.0,
731,458604,5,2,,103219982,3220,Active,,,16.87,IC50,Inhibition of Dengue virus type 2 NS5 RNA methyltransferase SAM site,Confirmatory,20108931.0,
732,463079,1,2,,47193718,3220,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
733,463082,1,1,,47193718,3220,Active,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
734,463096,1,1,,50105616,3220,Inactive,,,,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
735,463097,1,1,,50105616,3220,Inconclusive,7705682.0,51053.0,12.5893,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
736,463104,1,2,,47193718,3220,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
737,463106,1,2,,90340961,3220,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
738,463111,1,1,,47193718,3220,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
739,463141,1,2,,47193718,3220,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
740,463165,1,1,,47193718,3220,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
741,463189,1,1,,53777658,3220,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
742,463190,1,2,,47193718,3220,Active,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
743,463195,1,2,,47193718,3220,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
744,463210,1,2,,47193718,3220,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
745,463212,1,1,,47193718,3220,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
746,463213,1,3,,47193718,3220,Inactive,285809906.0,856395.0,,,Single concentration confirmation of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
747,466937,5,2,,103219982,3220,Unspecified,,,110.0,IC50,"Inhibition of Trypanosoma cruzi trans-sialidase containing catalytic domain (N58F, R200K) and lectin-like domain (S495 K, V496G, E520K, D593G, I597D, H599R) mutation expressed in Escherichia coli JM109 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay",Confirmatory,20097567.0,
748,466938,9,5,,103219982,3220,Unspecified,229462907.0,4759.0,760.0,IC50,Inhibition of human Neu2 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay,Confirmatory,20097567.0,
749,466939,3,3,,103219982,3220,Unspecified,,,,,Selectivity for Trypanosoma cruzi trans-sialidase mutant over human Neu2,Other,20097567.0,
750,472353,3,4,,103219982,3220,Active,,,,,Cytotoxicity against human THP1 cells after 48 hrs assessed morphological changes compound exposed to light for 20 mins before treatment,Other,19746917.0,
751,472354,3,4,,103219982,3220,Active,,,,,Cytotoxicity against human THP1 cells after 48 hrs assessed as morphological changes in the dark condition,Other,19746917.0,
752,485270,1,1,,47193718,3220,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
753,485272,1,1,,47193718,3220,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
754,485273,2,1,,47193718,3220,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
755,485275,1,3,,47193718,3220,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
756,485290,1,1,,17389019,3220,Inactive,20150581.0,,50.1187,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
757,485290,1,1,,50105616,3220,Inactive,20150581.0,,12.5893,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
758,485290,1,1,,50105617,3220,Inactive,20150581.0,,17.7828,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
759,485295,1,2,,90340961,3220,Active,30027657.0,,23.7781,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
760,485297,1,1,,90340961,3220,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
761,485298,1,1,,90340961,3220,Active,,,2.5929,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
762,485313,1,2,,90340961,3220,Inconclusive,255652944.0,4864.0,20.5962,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
763,485314,1,1,,50105616,3220,Active,4505931.0,5423.0,11.2202,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
764,485317,1,2,,47193718,3220,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
765,485342,1,2,,90340961,3220,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
766,485345,1,2,,90340961,3220,Inconclusive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
767,485346,1,1,,47193718,3220,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
768,485346,1,1,,47193718,3220,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
769,485366,1,2,,90340961,3220,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
770,485368,1,2,,90340961,3220,Inconclusive,72386991.0,3656265.0,23.9341,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
771,488745,1,4,,85231039,3220,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
772,488752,1,4,,85231039,3220,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
773,488772,1,1,,90340961,3220,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
774,488773,1,2,,90340961,3220,Inconclusive,8659577.0,58819.0,4.2284,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
775,488816,1,1,,90340961,3220,Active,4758356.0,2237.0,15.003,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
776,488837,1,1,,90340961,3220,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
777,488839,1,1,,56322653,3220,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
778,488839,1,1,,56322653,3220,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
779,488847,1,3,,47193718,3220,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
780,488862,1,1,,56322653,3220,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
781,488890,1,2,,47193718,3220,Inconclusive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
782,488895,1,2,,56322653,3220,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
783,488896,1,1,,56322653,3220,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
784,488899,1,1,,56322653,3220,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
785,488912,1,3,,47193718,3220,Active,262118306.0,123228.0,,,Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 8 (SENP8) using a Luminescent assay,Screening,,
786,488915,1,3,,47193718,3220,Active,6166485.0,26054.0,,,Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 6 (SENP6) using a Luminescent assay,Screening,,
787,488917,1,1,,47193718,3220,Active,120538355.0,57337.0,,,Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 7 (SENP7) using a Luminescent assay,Screening,,
788,488918,1,2,,47193718,3220,Active,14790119.0,836.0,,,Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay,Screening,,
789,488919,1,3,,47193718,3220,Active,262118306.0,123228.0,,,Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Luminescent Interference Counterscreen assay,Screening,,
790,488922,1,2,,47193718,3220,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
791,488949,1,2,,85231039,3220,Inconclusive,41055989.0,54737.0,39.8107,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
792,488949,1,2,,90340961,3220,Active,41055989.0,54737.0,10.6213,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
793,488953,1,1,,90340961,3220,Active,187960037.0,10951.0,22.3872,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
794,488965,1,2,,56322653,3220,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
795,488966,1,1,,56322653,3220,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
796,488975,1,2,,47193718,3220,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
797,488977,1,2,,47193718,3220,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
798,488978,1,1,,90340961,3220,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
799,488979,1,1,,50105616,3220,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
800,488980,1,1,,85231039,3220,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
801,488981,1,1,,90340961,3220,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
802,488982,1,1,,90340961,3220,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
803,488983,1,1,,90340961,3220,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
804,489030,2,1,,47193718,3220,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
805,489031,2,1,,47193718,3220,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
806,492243,5,2,,103219982,3220,Unspecified,,,20.0,IC50,Cytotoxicity against human KB cells after 72 hrs by MTT assay,Confirmatory,20561793.0,
807,492244,5,2,,103219982,3220,Unspecified,,,20.0,IC50,Cytotoxicity against human HL60 cells after 72 hrs by MTT assay,Confirmatory,20561793.0,
808,492245,5,2,,103219982,3220,Unspecified,,,20.0,IC50,Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay,Confirmatory,20561793.0,
809,492246,3,4,,103219982,3220,Unspecified,,,,,Displacement of ethidium bromide form calf thymus DNA by fluorometric assay,Other,20561793.0,
810,492953,1,1,,56322653,3220,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
811,492956,1,1,,56322653,3220,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
812,492972,1,1,,56322653,3220,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
813,493005,1,1,,47193718,3220,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
814,493008,1,1,,56322653,3220,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
815,493008,1,1,,56322653,3220,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
816,493008,1,1,,56322653,3220,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
817,493008,1,1,,56322653,3220,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
818,493011,1,1,,47193718,3220,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
819,493012,1,1,,47193718,3220,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
820,493036,1,2,,47193718,3220,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
821,493087,1,1,,56322653,3220,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
822,493091,1,1,,47193718,3220,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
823,493098,1,1,,47193718,3220,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
824,493106,1,1,,90340961,3220,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
825,493107,1,1,,90340961,3220,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
826,493127,1,1,,50105616,3220,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
827,493131,1,1,,56322653,3220,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
828,493153,1,1,,90340961,3220,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
829,493153,1,1,,90340961,3220,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
830,493160,1,1,,47193718,3220,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
831,493164,1,2,,90340961,3220,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
832,493164,1,2,,90340961,3220,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
833,493164,1,2,,90340961,3220,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
834,493187,1,2,,47193718,3220,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
835,493189,1,1,,50105616,3220,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
836,493244,1,1,,56322653,3220,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
837,493244,1,1,,56322653,3220,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
838,493244,1,1,,56322653,3220,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
839,493244,1,1,,56322653,3220,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
840,504326,1,2,,56322653,3220,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
841,504326,1,2,,56322653,3220,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
842,504327,1,1,,90340961,3220,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
843,504329,1,1,,56322653,3220,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
844,504332,1,1,,50105616,3220,Active,168985070.0,,8.9125,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
845,504332,1,1,,90340961,3220,Active,168985070.0,,1.6834,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
846,504339,1,1,,47193718,3220,Active,162330054.0,,44.6684,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
847,504357,1,1,,56322653,3220,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
848,504357,1,1,,56322653,3220,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
849,504364,1,1,,85231039,3220,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
850,504406,1,1,,47193718,3220,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
851,504408,2,1,,47193718,3220,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
852,504411,1,1,,56322653,3220,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
853,504414,1,1,,56322653,3220,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
854,504414,1,1,,56322653,3220,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
855,504423,1,1,,56322653,3220,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
856,504441,1,1,,56322653,3220,Active,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
857,504444,1,1,,47193718,3220,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
858,504454,1,3,,56322653,3220,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
859,504462,1,1,,47193718,3220,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
860,504490,1,2,,56322653,3220,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
861,504523,1,1,,56322653,3220,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
862,504523,1,1,,56322653,3220,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
863,504536,1,1,,90340961,3220,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
864,504547,1,1,,90340961,3220,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
865,504548,1,2,,90340961,3220,Inconclusive,157877932.0,5655980.0,37.933,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
866,504558,1,1,,56322653,3220,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
867,504577,2,2,,56322653,3220,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
868,504582,2,1,,56322653,3220,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
869,504621,1,1,,56322653,3220,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
870,504634,1,1,,56322653,3220,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
871,504648,1,1,,47193718,3220,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
872,504690,1,3,,47193718,3220,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
873,504692,2,2,,56322653,3220,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
874,504700,1,1,,56322653,3220,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
875,504700,1,1,,56322653,3220,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
876,504707,1,1,,56322653,3220,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
877,504707,1,1,,56322653,3220,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
878,504720,1,1,,47193718,3220,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
879,504734,1,1,,56322653,3220,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
880,504766,2,1,,56322653,3220,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
881,504775,1,1,,56322653,3220,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
882,504803,1,1,,56322653,3220,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
883,504810,1,2,,90340961,3220,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
884,504812,1,2,,90340961,3220,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
885,504821,1,1,,85231039,3220,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
886,504836,1,2,,90340961,3220,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
887,504845,1,1,,47193718,3220,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
888,504845,1,1,,90340961,3220,Inconclusive,86301163.0,5999.0,10.6213,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
889,504847,1,1,,47193718,3220,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
890,504847,1,1,,90340961,3220,Inconclusive,63054845.0,7421.0,89.1251,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
891,504865,1,1,,90340961,3220,Inconclusive,118600387.0,7398.0,50.1187,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
892,504884,1,2,,56322653,3220,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
893,504891,1,1,,47193718,3220,Inconclusive,5453898.0,5300.0,50.1187,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
894,504894,1,1,,47193718,3220,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
895,504937,1,2,,47193718,3220,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
896,521220,3,3,,103219982,3220,Inactive,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
897,524791,7,2,,103219982,3220,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
898,524794,7,1,,103219982,3220,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
899,524795,7,2,,103219982,3220,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
900,540253,1,1,,47193718,3220,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
901,540253,1,1,,47193718,3220,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
902,540253,1,1,,47193718,3220,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
903,540256,1,2,,50105616,3220,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
904,540256,1,2,,90340961,3220,Inconclusive,,,20.5878,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
905,540263,1,1,,47193718,3220,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
906,540263,1,1,,47193718,3220,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
907,540267,1,1,,47193718,3220,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
908,540276,1,2,,11111157,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
909,540276,1,2,,11111158,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
910,540276,1,2,,17389019,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
911,540276,1,2,,26753048,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
912,540276,1,2,,47193718,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
913,540276,1,2,,50105616,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
914,540276,1,2,,50105617,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
915,540276,1,2,,50105618,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
916,540276,1,2,,85231039,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
917,540276,1,2,,90340961,3220,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
918,540295,1,1,,56322653,3220,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
919,540303,1,1,,47193718,3220,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
920,540303,1,1,,47193718,3220,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
921,540303,1,1,,47193718,3220,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
922,540308,1,1,,56322653,3220,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
923,540317,1,1,,47193718,3220,Inconclusive,187960037.0,10951.0,22.3872,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
924,540336,1,1,,56322653,3220,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
925,540336,1,1,,56322653,3220,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
926,540364,1,2,,56322653,3220,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
927,566116,4,2,,103219982,3220,Active,,,2.0,IC50,Inhibition of CK2 assessed as inhibition of [gamma32P]GTP incorporation into substrate by liquid scintillation counting,Confirmatory,21174434.0,
928,588334,1,1,,56322653,3220,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
929,588335,1,1,,56322653,3220,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
930,588345,1,1,,56322653,3220,Inactive,6978787.0,25255.0,,AC50_uM,MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
931,588348,1,1,,56322653,3220,Inactive,,,,AC50_uM,MLPCN Dyrk1A Artifact Assay Measured in Biochemical System Using Plate Reader - 2124-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
932,588349,1,1,,90340961,3220,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
933,588352,1,2,,56322653,3220,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
934,588354,1,1,,56322653,3220,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
935,588358,1,2,,56322653,3220,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
936,588378,1,1,,90340961,3220,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
937,588379,1,2,,124880055,3220,Inconclusive,13399304.0,60489.0,23.715,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
938,588391,1,1,,56322653,3220,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
939,588405,1,1,,56322653,3220,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
940,588413,1,2,,47193718,3220,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
941,588436,1,1,,56322653,3220,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
942,588453,1,1,,47193718,3220,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
943,588453,1,1,,85231039,3220,Inconclusive,8659577.0,58819.0,19.9526,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
944,588453,1,1,,90340961,3220,Inconclusive,8659577.0,58819.0,4.2284,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
945,588456,1,1,,47193718,3220,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
946,588456,1,1,,90340961,3220,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
947,588458,1,1,,56322653,3220,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
948,588473,1,1,,47193718,3220,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
949,588473,1,1,,47193718,3220,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
950,588475,1,2,,47193718,3220,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
951,588475,1,2,,47193718,3220,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
952,588478,1,2,,124799524,3220,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
953,588489,1,1,,56322653,3220,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
954,588492,1,1,,56322653,3220,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
955,588493,1,2,,56322653,3220,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
956,588497,1,2,,56322653,3220,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
957,588497,1,2,,56322653,3220,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
958,588497,1,2,,56322653,3220,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
959,588499,1,3,,56322653,3220,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
960,588499,1,3,,56322653,3220,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
961,588499,1,3,,56322653,3220,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
962,588501,1,2,,56322653,3220,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
963,588501,1,2,,56322653,3220,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
964,588501,1,2,,56322653,3220,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
965,588511,1,2,,47193718,3220,Active,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
966,588513,1,1,,17389019,3220,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
967,588513,1,1,,26753048,3220,Inconclusive,348019627.0,2099.0,19.9526,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
968,588514,1,1,,17389019,3220,Inconclusive,348019627.0,2099.0,44.6684,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
969,588514,1,1,,26753048,3220,Inconclusive,348019627.0,2099.0,50.1187,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
970,588515,1,1,,17389019,3220,Inconclusive,124375976.0,367.0,35.4813,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
971,588515,1,1,,26753048,3220,Inconclusive,124375976.0,367.0,22.3872,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
972,588516,1,1,,17389019,3220,Inconclusive,124375976.0,367.0,25.1189,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
973,588516,1,1,,26753048,3220,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
974,588526,1,1,,17389019,3220,Inconclusive,325495553.0,9971.0,44.6684,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
975,588526,1,1,,26753048,3220,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
976,588527,1,1,,17389019,3220,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
977,588527,1,1,,26753048,3220,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
978,588532,1,1,,17389019,3220,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
979,588532,1,1,,26753048,3220,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
980,588533,1,1,,17389019,3220,Inconclusive,311348376.0,2908.0,10.0,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
981,588533,1,1,,26753048,3220,Inconclusive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
982,588534,1,1,,17389019,3220,Inconclusive,216409690.0,5467.0,19.9526,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
983,588534,1,1,,26753048,3220,Inconclusive,216409690.0,5467.0,5.6234,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
984,588535,1,1,,17389019,3220,Inconclusive,216409690.0,5467.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
985,588535,1,1,,26753048,3220,Inconclusive,216409690.0,5467.0,15.8489,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
986,588536,1,1,,17389019,3220,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
987,588536,1,1,,26753048,3220,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
988,588537,1,1,,17389019,3220,Inconclusive,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
989,588537,1,1,,26753048,3220,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
990,588541,1,1,,17389019,3220,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
991,588541,1,1,,26753048,3220,Inconclusive,216409708.0,7421.0,25.1189,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
992,588543,1,1,,17389019,3220,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
993,588543,1,1,,26753048,3220,Inconclusive,216409708.0,7421.0,25.1189,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
994,588544,1,1,,17389019,3220,Inconclusive,325495497.0,6256.0,15.8489,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
995,588544,1,1,,26753048,3220,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
996,588545,1,1,,17389019,3220,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
997,588545,1,1,,26753048,3220,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
998,588546,1,1,,17389019,3220,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
999,588546,1,1,,26753048,3220,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
1000,588547,1,1,,17389019,3220,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
1001,588547,1,1,,26753048,3220,Inconclusive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
1002,588549,1,1,,56322653,3220,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1003,588579,1,1,,47193718,3220,Inconclusive,7705344.0,51426.0,89.1251,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1004,588579,1,1,,90340961,3220,Inconclusive,7705344.0,51426.0,33.5875,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1005,588579,1,1,,124880055,3220,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1006,588590,1,1,,47193718,3220,Inconclusive,154350220.0,11201.0,3.9811,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1007,588590,1,1,,50105616,3220,Inconclusive,154350220.0,11201.0,28.1838,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1008,588591,1,1,,47193718,3220,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1009,588591,1,1,,50105616,3220,Inconclusive,5729982.0,5429.0,15.8489,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1010,588621,1,1,,56322653,3220,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
1011,588627,1,1,,47193718,3220,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
1012,588664,1,2,,56322653,3220,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1013,588664,1,2,,56322653,3220,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1014,588674,1,2,,56322653,3220,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1015,588675,1,1,,47193718,3220,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
1016,588676,1,1,,47193718,3220,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
1017,588689,1,1,,56322653,3220,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
1018,588692,2,1,,56322653,3220,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1019,588726,1,2,,56322653,3220,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1020,588727,1,1,,56322653,3220,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
1021,588795,1,1,,47193718,3220,Active,4758356.0,2237.0,39.8107,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1022,588795,1,1,,90340961,3220,Inconclusive,4758356.0,2237.0,6.7016,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1023,588812,1,1,,17389019,3220,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1024,588812,1,1,1.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1025,588812,1,1,2.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1026,588812,1,1,3.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1027,588812,1,1,4.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1028,588812,1,1,5.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1029,588812,1,1,6.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1030,588812,1,1,7.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1031,588812,1,1,8.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1032,588812,1,1,9.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1033,588812,1,1,10.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1034,588812,1,1,11.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1035,588812,1,1,12.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1036,588812,1,1,13.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1037,588812,1,1,14.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1038,588812,1,1,15.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1039,588812,1,1,16.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1040,588812,1,1,17.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1041,588812,1,1,18.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1042,588812,1,1,19.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1043,588812,1,1,20.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1044,588812,1,1,21.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1045,588812,1,1,22.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1046,588812,1,1,23.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1047,588812,1,1,24.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1048,588812,1,1,25.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1049,588812,1,1,26.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1050,588812,1,1,27.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1051,588812,1,1,28.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1052,588812,1,1,29.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1053,588812,1,1,30.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1054,588812,1,1,31.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1055,588812,1,1,32.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1056,588812,1,1,33.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1057,588812,1,1,34.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1058,588812,1,1,35.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1059,588812,1,1,36.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1060,588812,1,1,37.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1061,588812,1,1,38.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1062,588812,1,1,39.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1063,588812,1,1,40.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1064,588812,1,1,41.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1065,588812,1,1,42.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1066,588812,1,1,43.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1067,588812,1,1,44.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1068,588812,1,1,45.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1069,588812,1,1,46.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1070,588812,1,1,47.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1071,588812,1,1,48.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1072,588812,1,1,49.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1073,588812,1,1,50.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1074,588812,1,1,51.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1075,588812,1,1,52.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1076,588812,1,1,53.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1077,588812,1,1,54.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1078,588812,1,1,55.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1079,588812,1,1,56.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1080,588812,1,1,57.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1081,588812,1,1,58.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1082,588812,1,1,59.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1083,588812,1,1,60.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1084,588812,1,1,61.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1085,588812,1,1,62.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1086,588812,1,1,63.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1087,588812,1,1,64.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1088,588812,1,1,65.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1089,588812,1,1,66.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1090,588812,1,1,67.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1091,588812,1,1,68.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1092,588812,1,1,69.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1093,588812,1,1,70.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1094,588812,1,1,71.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1095,588812,1,1,72.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1096,588812,1,1,73.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1097,588812,1,1,74.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1098,588812,1,1,75.0,17389019,3220,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1099,588812,1,1,76.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1100,588812,1,1,77.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1101,588812,1,1,78.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1102,588812,1,1,79.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1103,588812,1,1,80.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1104,588812,1,1,81.0,17389019,3220,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1105,588813,1,1,,17389019,3220,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1106,588813,1,1,1.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1107,588813,1,1,2.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1108,588813,1,1,3.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1109,588813,1,1,4.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1110,588813,1,1,5.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1111,588813,1,1,6.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1112,588813,1,1,7.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1113,588813,1,1,8.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1114,588813,1,1,9.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1115,588813,1,1,10.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1116,588813,1,1,11.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1117,588813,1,1,12.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1118,588813,1,1,13.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1119,588813,1,1,14.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1120,588813,1,1,15.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1121,588813,1,1,16.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1122,588813,1,1,17.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1123,588813,1,1,18.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1124,588813,1,1,19.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1125,588813,1,1,20.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1126,588813,1,1,21.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1127,588813,1,1,22.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1128,588813,1,1,23.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1129,588813,1,1,24.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1130,588813,1,1,25.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1131,588813,1,1,26.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1132,588813,1,1,27.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1133,588813,1,1,28.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1134,588813,1,1,29.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1135,588813,1,1,30.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1136,588813,1,1,31.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1137,588813,1,1,32.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1138,588813,1,1,33.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1139,588813,1,1,34.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1140,588813,1,1,35.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1141,588813,1,1,36.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1142,588813,1,1,37.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1143,588813,1,1,38.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1144,588813,1,1,39.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1145,588813,1,1,40.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1146,588813,1,1,41.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1147,588813,1,1,42.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1148,588813,1,1,43.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1149,588813,1,1,44.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1150,588813,1,1,45.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1151,588813,1,1,46.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1152,588813,1,1,47.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1153,588813,1,1,48.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1154,588813,1,1,49.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1155,588813,1,1,50.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1156,588813,1,1,51.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1157,588813,1,1,52.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1158,588813,1,1,53.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1159,588813,1,1,54.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1160,588813,1,1,55.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1161,588813,1,1,56.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1162,588813,1,1,57.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1163,588813,1,1,58.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1164,588813,1,1,59.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1165,588813,1,1,60.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1166,588813,1,1,61.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1167,588813,1,1,62.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1168,588813,1,1,63.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1169,588813,1,1,64.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1170,588813,1,1,65.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1171,588813,1,1,66.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1172,588813,1,1,67.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1173,588813,1,1,68.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1174,588813,1,1,69.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1175,588813,1,1,70.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1176,588813,1,1,71.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1177,588813,1,1,72.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1178,588813,1,1,73.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1179,588813,1,1,74.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1180,588813,1,1,75.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1181,588813,1,1,76.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1182,588813,1,1,77.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1183,588813,1,1,78.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1184,588813,1,1,79.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1185,588813,1,1,80.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1186,588813,1,1,81.0,17389019,3220,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1187,588814,1,3,,56322653,3220,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1188,588819,1,4,,56322653,3220,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1189,588834,2,1,,17389019,3220,Inconclusive,325651834.0,3757.0,39.8107,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1190,588834,2,1,,50105616,3220,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1191,588850,1,1,,56322653,3220,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1192,588852,1,3,,56322653,3220,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1193,588855,1,1,,47193718,3220,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1194,588856,1,1,,47193718,3220,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1195,602123,1,1,,56322653,3220,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1196,602141,1,1,,56322653,3220,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1197,602162,1,1,,56322653,3220,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1198,602163,1,1,,56322653,3220,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1199,602179,1,2,,47193718,3220,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1200,602229,1,1,,56322653,3220,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1201,602233,1,1,,47193718,3220,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1202,602244,1,2,,56322653,3220,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1203,602247,1,2,,56322653,3220,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1204,602248,1,2,,56322653,3220,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1205,602250,1,2,,56322653,3220,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1206,602252,1,1,,56322653,3220,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1207,602252,1,1,,56322653,3220,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1208,602261,1,1,,56322653,3220,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1209,602274,1,2,,56322653,3220,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1210,602281,1,1,,56322653,3220,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1211,602281,1,1,,56322653,3220,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1212,602310,1,2,,47193718,3220,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1213,602313,1,1,,47193718,3220,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1214,602329,1,1,,56322653,3220,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1215,602332,1,1,,47193718,3220,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1216,602332,1,1,,90340961,3220,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1217,602332,1,1,,124880055,3220,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1218,602340,1,2,,56322653,3220,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1219,602342,2,1,,56322653,3220,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1220,602346,1,1,,56322653,3220,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1221,602363,1,1,,56322653,3220,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1222,602393,1,1,,56322653,3220,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1223,602396,1,2,,56322653,3220,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1224,602399,1,2,,56322653,3220,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1225,602405,1,1,,56322653,3220,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1226,602410,1,1,,56322653,3220,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1227,602429,1,1,,56322653,3220,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1228,602438,1,1,,56322653,3220,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1229,602440,1,1,,56322653,3220,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1230,602449,1,2,,56322653,3220,Active,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1231,602481,1,1,,56322653,3220,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1232,607593,3,3,,103219982,3220,Active,,,31.0,IC50,Cytotoxicity against human U373 cells after 72 hrs by MTT assay,Confirmatory,21696954.0,
1233,607594,3,3,,103219982,3220,Active,,,29.0,IC50,Cytotoxicity against human OE21 cells after 72 hrs by MTT assay,Confirmatory,21696954.0,
1234,607595,3,2,,103219982,3220,Active,,,28.0,IC50,Cytotoxicity against human A549 cells after 72 hrs by MTT assay,Confirmatory,21696954.0,
1235,607596,3,2,,103219982,3220,Active,,,35.0,IC50,Cytotoxicity against human PC3 cells after 72 hrs by MTT assay,Confirmatory,21696954.0,
1236,607597,3,2,,103219982,3220,Active,,,35.0,IC50,Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay,Confirmatory,21696954.0,
1237,607598,3,2,,103219982,3220,Active,,,27.0,IC50,Cytotoxicity against human LoVo cells after 72 hrs by MTT assay,Confirmatory,21696954.0,
1238,607600,1,3,,103219982,3220,Unspecified,,,,,Induction of human U373 cell death assessed as morphological changes at MTT assay-related IC50 after 72 hrs by quantitative video microscopy,Other,21696954.0,
1239,607601,1,4,,103219982,3220,Unspecified,,,,,Cytotoxicity against human U373 cells assessed as growth inhibition at MTT assay-related IC50 by quantitative video microscopy relative to control,Other,21696954.0,
1240,623870,1,1,,56322653,3220,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1241,623870,1,1,,56322653,3220,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1242,623877,1,1,,56322653,3220,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1243,623901,1,1,,56322653,3220,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
1244,624037,1,3,,56322653,3220,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1245,624038,1,3,,56322653,3220,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1246,624040,1,3,,56322653,3220,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1247,624125,1,4,,56322653,3220,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1248,624126,1,3,,56322653,3220,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1249,624127,1,2,,56322653,3220,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1250,624146,1,1,,90340961,3220,Inconclusive,71051501.0,2744.0,2.8184,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
1251,624147,1,1,,90340961,3220,Inconclusive,62359610.0,,9.5283,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
1252,624148,1,2,,90340961,3220,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
1253,624149,1,1,,90340961,3220,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
1254,624156,1,1,,85789231,3220,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1255,624168,1,1,,56322653,3220,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1256,624169,1,1,,56322653,3220,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1257,624170,1,1,,47193718,3220,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1258,624171,1,1,,47193718,3220,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1259,624172,1,1,,47193718,3220,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1260,624173,1,3,,47193718,3220,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1261,624178,1,1,,47193718,3220,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1262,624202,1,1,,47193718,3220,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1263,624204,1,2,,56322653,3220,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1264,624246,1,1,,47193718,3220,Inactive,343478176.0,2078.0,28.1838,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1265,624256,1,2,,56322653,3220,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1266,624263,1,1,,47193718,3220,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1267,624263,1,1,,47193718,3220,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1268,624267,1,2,,56322653,3220,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1269,624267,1,2,,56322653,3220,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1270,624268,1,3,,56322653,3220,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1271,624288,1,1,,47193718,3220,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1272,624296,1,1,,47193718,3220,Inactive,7705682.0,51053.0,1.8356,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1273,624297,1,1,,47193718,3220,Inactive,7705682.0,51053.0,25.929000000000002,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1274,624304,1,2,,56322653,3220,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1275,624330,1,2,,56322653,3220,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1276,624352,1,1,,56322653,3220,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1277,624354,1,1,,56322653,3220,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1278,624377,1,1,,56322653,3220,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
1279,624414,1,1,,47193718,3220,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1280,624415,1,2,,47193718,3220,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1281,624416,1,1,,56322653,3220,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
1282,624417,1,1,,47193718,3220,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1283,624418,1,1,,47193718,3220,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1284,624455,1,1,,90340961,3220,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
1285,624463,1,1,,47193718,3220,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1286,624464,1,1,,47193718,3220,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1287,624465,1,1,,47193718,3220,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1288,624466,1,3,,56322653,3220,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1289,624467,1,1,,56322653,3220,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1290,624483,1,1,,56322653,3220,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1291,624504,1,1,,56322653,3220,Active,,,,,Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay,Screening,,
1292,624606,1,9,,103219982,3220,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
1293,624607,1,9,,103219982,3220,Unspecified,549152.0,54659.0,,,Specific activity of expressed human recombinant UGT1A3,Other,10836148.0,
1294,624608,3,2,,103219982,3220,Unspecified,136731.0,54657.0,,,Specific activity of expressed human recombinant UGT1A4,Other,10836148.0,
1295,624609,1,9,,103219982,3220,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
1296,624611,1,9,,103219982,3220,Unspecified,29839637.0,54576.0,,,Specific activity of expressed human recombinant UGT1A8,Other,10836148.0,
1297,624612,1,9,,103219982,3220,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
1298,624613,1,9,,103219982,3220,Unspecified,29839636.0,54575.0,,,Specific activity of expressed human recombinant UGT1A10,Other,10836148.0,
1299,624616,1,8,,103219982,3220,Unspecified,332278237.0,7366.0,,,Specific activity of expressed human recombinant UGT2B15,Other,10836148.0,
1300,634900,3,3,,103219982,3220,Active,,,16.0,IC50,Cytotoxicity against human HO8910 cells after 2 days by alamar blue assay,Confirmatory,22093761.0,
1301,634901,3,3,,103219982,3220,Unspecified,,,61.3,IC50,Cytotoxicity against human SGC7901 cells after 2 days by alamar blue assay,Confirmatory,22093761.0,
1302,634902,3,2,,103219982,3220,Active,,,13.1,IC50,Cytotoxicity against human HepG2 cells after 2 days by alamar blue assay,Confirmatory,22093761.0,
1303,634904,3,2,,103219982,3220,Active,,,1.3,IC50,Cytotoxicity against human HEK293 cells after 2 days by alamar blue assay,Confirmatory,22093761.0,
1304,637923,5,2,,103219982,3220,Active,,,3.5,IC50,Inhibition of PRL3 after 1 hr by DiFMUP assay,Confirmatory,22137788.0,
1305,637924,6,2,,103219982,3220,Unspecified,68566154.0,11156.0,,IC50,Inhibition of PRL-3-mediated cell migration in human DLD1 cells after 15 hrs by crystal violet staining based microscopic assay,Confirmatory,22137788.0,
1306,637925,1,9,,103219982,3220,Unspecified,68566154.0,11156.0,,,Inhibition of PRL-3-mediated cell migration in human DLD1 cells at 40 uM after 15 hrs by crystal violet staining based microscopic assay,Other,22137788.0,
1307,637926,1,4,,103219982,3220,Unspecified,,,,,Cytotoxicity against human DLD1 cells expressing PRL-3 assessed as inhibition of cell proliferation up to 50 uM after 24 hrs by WST-1 assay,Other,22137788.0,
1308,637927,6,2,,103219982,3220,Unspecified,68566154.0,11156.0,,IC50,Inhibition of PRL-3-mediated cell invasion in human DLD1 cells after 20 hrs using crystal violet staining by Matrigel invasion assay,Confirmatory,22137788.0,
1309,637928,1,9,,103219982,3220,Unspecified,68566154.0,11156.0,,,Inhibition of PRL-3-mediated cell invasion in human DLD1 cells at 40 uM after 20 hrs using crystal violet staining by Matrigel invasion assay,Other,22137788.0,
1310,637929,1,9,,103219982,3220,Active,68566154.0,11156.0,,,Inhibition of PRL3-mediated ezrin phosphorylation in human DLD1 cells assessed as increase in alpha-ERM-Thr567 phosphorylation at 10 to 40 uM after 15 hrs by chemiluminescence method relative to control,Other,22137788.0,
1311,637930,1,9,,103219982,3220,Inactive,125987826.0,7430.0,,,Inhibition of ezrin phosphorylation in human DLD1 cells assessed as increase in alpha-ERM-Thr567 phosphorylation at 10 to 40 uM after 15 hrs by chemiluminescence method,Other,22137788.0,
1312,641152,3,2,,103219982,3220,Active,,,5.3,IC50,Growth inhibition of human HCT116 cells overexpressing PI3Kalpha after 48 hrs by MTT assay,Confirmatory,22212721.0,
1313,641153,3,2,,103219982,3220,Active,,,3.8,IC50,Growth inhibition of human HCT116 cells overexpressing PI3Kalpha H1047R mutant after 48 hrs by MTT assay,Confirmatory,22212721.0,
1314,641154,3,2,,103219982,3220,Active,,,6.2,IC50,Growth inhibition of human HCT116 cells after 48 hrs by MTT assay,Confirmatory,22212721.0,
1315,641155,1,9,,103219982,3220,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha in human HCT116 cells using [32P]ATP at 10 uM after 10 mins,Other,22212721.0,
1316,641157,1,5,,103219982,3220,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha H1047R mutant in human HCT116 cells using [32P]ATP at 10 uM after 10 mins,Other,22212721.0,
1317,641159,1,9,,103219982,3220,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha in human HCT116 cells assessed as inhibition of Akt Ser473 phosphorylation at 10 uM by immunoblot analysis,Other,22212721.0,
1318,641160,1,5,,103219982,3220,Active,126302584.0,5290.0,,,Inhibition of PI3Kalpha H1047R mutant in human HCT116 cells assessed as inhibition of Akt Ser473 phosphorylation at 10 uM by immunoblot analysis,Other,22212721.0,
1319,641163,1,4,,103219982,3220,Active,,,,,Inhibition of Akt expression in human HCT116 cells at 10 uM by immunoblot analysis,Other,22212721.0,
1320,641164,1,4,,103219982,3220,Unspecified,,,,,Induction of apoptosis in human HCT116 cells assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control,Other,22212721.0,
1321,641165,1,4,,103219982,3220,Unspecified,,,,,Induction of apoptosis in human HCT116 cells overexpressing PI3Kalpha assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control,Other,22212721.0,
1322,641166,1,4,,103219982,3220,Unspecified,,,,,Induction of apoptosis in human HCT116 cells overexpressing PI3Kalpha H1047R mutant assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control,Other,22212721.0,
1323,650668,3,2,,103219982,3220,Active,,,0.89,IC50,Inhibition of rat liver casein kinase-2 preincubated for 5 mins prior ATP addition measured after 40 mins,Confirmatory,22377675.0,
1324,650670,4,2,,103219982,3220,Active,,,0.46,IC50,Inhibition of human CSNK2A1/2B expressed in Escherichia coli BL21(DE3) using RRRDDDSDDD as substrate after 15 mins by scintillation counting,Confirmatory,22377675.0,
1325,651560,1,1,,56322653,3220,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1326,651572,1,2,,56322653,3220,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1327,651582,1,1,,56322653,3220,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1328,651602,1,1,,56322653,3220,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1329,651602,1,1,,56322653,3220,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1330,651602,1,1,,56322653,3220,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1331,651610,2,1,,56322653,3220,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1332,651631,4,1,,144210197,3220,Active,269849759.0,7157.0,10.6233,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1333,651631,4,1,,144213535,3220,Inconclusive,269849759.0,7157.0,17.2289,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1334,651632,4,1,,144210197,3220,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1335,651632,4,1,,144213535,3220,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1336,651633,4,1,,144210197,3220,Inactive,,,15.0057,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1337,651633,4,1,,144213535,3220,Active,,,61.1306,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1338,651634,4,1,,144210197,3220,Active,,,23.7825,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1339,651634,4,1,,144213535,3220,Active,,,54.4827,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1340,651635,1,3,,47193718,3220,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1341,651635,1,3,,90340961,3220,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1342,651636,1,1,,56322653,3220,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1343,651640,1,1,,56322653,3220,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1344,651644,1,1,,47193718,3220,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1345,651647,1,1,,56322653,3220,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1346,651654,1,1,,56322653,3220,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1347,651658,1,1,,56322653,3220,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1348,651661,2,1,,56322653,3220,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1349,651687,1,1,,56322653,3220,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1350,651699,1,1,,56322653,3220,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1351,651699,1,1,,56322653,3220,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1352,651702,1,2,,56322653,3220,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1353,651704,2,1,,56322653,3220,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1354,651710,1,1,,56322653,3220,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1355,651711,2,1,,56322653,3220,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1356,651718,1,2,,56322653,3220,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1357,651719,1,2,,56322653,3220,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
1358,651723,1,1,,56322653,3220,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
1359,651724,1,1,,47193718,3220,Inconclusive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1360,651725,1,1,,47193718,3220,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1361,651741,1,1,,17389019,3220,Active,20149576.0,4780.0,18.8336,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1362,651741,1,1,,124880057,3220,Active,20149576.0,4780.0,9.6885,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1363,651743,1,1,,17389019,3220,Active,269849759.0,7157.0,15.8489,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1364,651743,1,1,,26753048,3220,Active,269849759.0,7157.0,22.3872,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1365,651749,1,1,,17389019,3220,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1366,651749,1,1,,26753048,3220,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1367,651751,1,1,,17389019,3220,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1368,651751,1,1,,26753048,3220,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1369,651754,1,1,,17389019,3220,Active,,,2.9849,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
1370,651755,1,1,,17389019,3220,Active,,,3.7578,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
1371,651757,1,1,,17389019,3220,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
1372,651758,1,1,,17389019,3220,Active,186368.0,3576.0,66.8242,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
1373,651768,1,2,,47193718,3220,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1374,651777,1,1,,17389019,3220,Active,51095037.0,196.0,44.6684,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1375,651777,1,1,,26753048,3220,Active,51095037.0,196.0,44.6684,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1376,651778,1,1,,17389019,3220,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1377,651778,1,1,,26753048,3220,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1378,651800,1,1,,56322653,3220,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1379,651802,1,1,,17389019,3220,Active,49066040.0,6097.0,42.1632,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1380,651819,1,1,,47193718,3220,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1381,651820,1,1,,47193718,3220,Inactive,,,10.0,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1382,651821,2,4,,56322653,3220,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1383,651828,1,2,,121361429,3220,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
1384,651838,1,1,,17389019,3220,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1385,651838,1,1,,26753048,3220,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1386,651838,1,1,1.0,17389019,3220,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1387,651838,1,1,1.0,26753048,3220,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1388,651838,1,1,2.0,17389019,3220,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1389,651838,1,1,2.0,26753048,3220,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1390,651838,1,1,3.0,17389019,3220,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1391,651838,1,1,3.0,26753048,3220,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1392,651838,1,1,4.0,17389019,3220,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1393,651838,1,1,4.0,26753048,3220,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1394,651838,1,1,5.0,17389019,3220,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1395,651838,1,1,5.0,26753048,3220,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1396,651838,1,1,6.0,17389019,3220,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1397,651838,1,1,6.0,26753048,3220,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1398,651838,1,1,7.0,17389019,3220,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1399,651838,1,1,7.0,26753048,3220,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1400,651838,1,1,8.0,17389019,3220,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1401,651838,1,1,8.0,26753048,3220,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1402,651957,1,1,,56322653,3220,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1403,651958,1,1,,56322653,3220,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1404,651965,1,1,,47193718,3220,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1405,651999,1,1,,56322653,3220,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1406,652010,1,1,,56322653,3220,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1407,652017,1,1,,56322653,3220,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1408,652025,1,1,,47193718,3220,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1409,652039,1,1,,56322653,3220,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1410,652048,1,2,,47193718,3220,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1411,652051,1,1,,47193718,3220,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1412,652054,1,1,,47193718,3220,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1413,652067,1,4,,56322653,3220,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1414,652104,1,1,,47193718,3220,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1415,652105,1,1,,47193718,3220,Active,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1416,652106,1,1,,47193718,3220,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1417,652106,1,1,,90340961,3220,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1418,652115,1,1,,56322653,3220,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1419,652126,1,3,,56322653,3220,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1420,652154,1,1,,56322653,3220,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1421,652162,2,1,,56322653,3220,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1422,652163,1,1,,56322653,3220,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1423,652197,1,1,,56322653,3220,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1424,652257,1,1,,56322653,3220,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1425,670257,4,1,,103219982,3220,Active,,,2.0,IC50,Inhibition of CK2,Confirmatory,22633690.0,
1426,686940,1,1,,56322653,3220,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1427,686964,1,1,,56322653,3220,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1428,686970,1,2,,47193718,3220,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1429,686971,1,2,,47193718,3220,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1430,686978,1,1,,47193718,3220,Inconclusive,79154014.0,55775.0,6.5131,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1431,686978,1,1,,124880055,3220,Active,79154014.0,55775.0,21.136,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1432,686979,1,1,,47193718,3220,Active,79154014.0,55775.0,18.3564,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1433,686979,1,1,,124880055,3220,Inconclusive,79154014.0,55775.0,11.8856,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1434,686992,2,1,,56322653,3220,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1435,687014,1,1,,56322653,3220,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1436,687016,1,1,,56322653,3220,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1437,687035,1,1,,163564506,3220,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1438,687037,1,3,,163564506,3220,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
1439,687695,2,2,,103219982,3220,Unspecified,,,70.0,IC50,Cytotoxicity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,22901410.0,
1440,687696,2,3,,103219982,3220,Unspecified,,,70.0,IC50,Cytotoxicity against human BGC cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,22901410.0,
1441,687697,2,2,,103219982,3220,Unspecified,,,70.0,IC50,Cytotoxicity against human AGS cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,22901410.0,
1442,687698,2,3,,103219982,3220,Unspecified,,,70.0,IC50,Cytotoxicity against human HELF cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,22901410.0,
1443,697852,1,7,,103219982,3220,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1444,697853,1,7,,103219982,3220,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1445,720504,1,1,,47193718,3220,Inconclusive,21359873.0,5347.0,26.6795,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1446,720508,1,1,,56322653,3220,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1447,720509,1,1,,56322653,3220,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1448,720511,1,1,,56322653,3220,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1449,720516,2,1,,144210197,3220,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1450,720516,2,1,,144213535,3220,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1451,720532,1,1,,124880055,3220,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1452,720533,1,1,,124880055,3220,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1453,720538,1,2,,90340961,3220,Inactive,220983390.0,410.0,2.1331,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1454,720542,1,2,,47193718,3220,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1455,720543,1,1,,56322653,3220,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1456,720551,1,2,,47193718,3220,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1457,720552,2,1,,144210197,3220,Active,269849759.0,7157.0,16.8367,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1458,720552,2,1,,144213535,3220,Inconclusive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1459,720553,1,2,,47193718,3220,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1460,720559,1,2,,90340961,3220,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1461,720572,1,2,,90340961,3220,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1462,720573,1,2,,90340961,3220,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1463,720579,2,1,,47193718,3220,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1464,720580,1,1,,47193718,3220,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1465,720582,1,1,,56322653,3220,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1466,720596,1,1,,56322653,3220,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1467,720634,2,1,,144210197,3220,Active,,,15.0057,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1468,720634,2,1,,144213535,3220,Inconclusive,,,4.3277,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1469,720635,2,1,,144210197,3220,Active,,,1.6837,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1470,720635,2,1,,144213535,3220,Active,,,0.5448,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1471,720636,1,1,,17389019,3220,Inconclusive,20149576.0,4780.0,9.4392,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1472,720636,1,1,,124880057,3220,Inconclusive,20149576.0,4780.0,7.6959,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1473,720637,2,1,,144210197,3220,Active,,,2.03982,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1474,720637,2,1,,144213535,3220,Active,,,0.863492,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1475,720647,1,2,,56322653,3220,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1476,720648,1,1,,56322653,3220,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1477,720652,1,1,,17389019,3220,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1478,720653,1,1,,17389019,3220,Inconclusive,,,56.2341,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1479,720653,1,1,,26753048,3220,Inconclusive,,,44.6684,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1480,720659,1,1,,17389019,3220,Inconclusive,325495557.0,8856.0,50.1187,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1481,720659,1,1,,26753048,3220,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1482,720674,2,2,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1483,720674,2,2,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1484,720675,2,2,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1485,720675,2,2,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1486,720678,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1487,720678,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1488,720679,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1489,720679,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1490,720680,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1491,720680,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1492,720681,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1493,720681,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1494,720682,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1495,720682,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1496,720683,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1497,720683,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1498,720684,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1499,720684,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1500,720685,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1501,720685,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1502,720686,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1503,720686,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1504,720687,2,2,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1505,720687,2,2,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1506,720691,4,1,,144210197,3220,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1507,720691,4,1,,144213535,3220,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1508,720692,3,1,,144210197,3220,Inconclusive,311348376.0,2908.0,6.7615,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1509,720692,3,1,,144213535,3220,Inconclusive,311348376.0,2908.0,48.9722,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1510,720693,3,1,,144210197,3220,Inconclusive,,,30.2023,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1511,720693,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1512,720700,1,4,,56322653,3220,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1513,720702,1,1,,56322653,3220,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1514,720704,1,4,,56322653,3220,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1515,720707,1,2,,47193718,3220,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1516,720708,1,2,,47193718,3220,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1517,720709,1,2,,47193718,3220,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1518,720711,1,2,,47193718,3220,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1519,720719,2,1,,144210197,3220,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1520,720719,2,1,,144213535,3220,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1521,720725,2,1,,144210197,3220,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1522,720725,2,1,,144213535,3220,Active,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1523,733834,3,1,,103219982,3220,Inactive,,,,,Induction of yorB promoter in Bacillus subtilis IS34 after 3 hrs at 0.01 to 100 ug/ml by luciferase reporter gene assay,Other,23534483.0,
1524,733835,1,2,,103219982,3220,Inactive,,,,,Induction of recA promoter in Bacillus subtilis YB3001 using 4-methylumbelliferyl beta D-galactopyranoside as substrate incubated for 3 hrs prior to substrate addition measured after 1 hr by beta galactosidase reporter gene assay relative to control,Other,23534483.0,
1525,733837,1,2,,103219982,3220,Inactive,,,,,Induction of bmrC promoter in Bacillus subtilis IS34 promoter at 64 ug/mL after 3 hrs by luciferase reporter gene assay,Other,23534483.0,
1526,733838,1,2,,103219982,3220,Inactive,,,,,Induction of helD promoter in Bacillus subtilis IS34 at 64 ug/mL after 3 hrs by luciferase reporter gene assay,Other,23534483.0,
1527,733839,1,2,,103219982,3220,Inactive,,,,,Induction of liaI promoter in Bacillus subtilis IS34 promoter at 64 ug/mL after 3 hrs by luciferase reporter gene assay,Other,23534483.0,
1528,733842,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against Bacillus subtilis subsp. subtilis str. 168 trpC2 assessed as concentration required for partial growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1529,733843,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against doxycycline, kanamycin-resistant Klebsiella pneumoniae ATCC 27799 assessed as growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1530,733844,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against ciprofloxacin-resistant Escherichia coli WT-3-1 MB2 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1531,733845,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1532,733846,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against Bacillus subtilis subsp. subtilis str. 168 trpC2 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1533,733847,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against clarithromycin, erythromycin, telithromycin, vancomycin-resistant Enterococcus faecium 6011 assessed as growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1534,733848,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against clarithromycin, erythromycin, moxifloxacin, telithromycin, vancomycin-resistant Enterococcus faecalis UW 2689 assessed as growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1535,733849,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against doxycycline-intermediate Streptococcus agalactiae 013761 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1536,733850,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1537,734243,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against amoxicillin, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, fosmidomycin, gentamycin, kanamycin, nitrofurantoin, telithromycin, methicillin-resistant Staphylococcus aureus 25697 assessed as growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1538,734244,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against ceftazidime, clarithromycin, ciprofloxacin, clindamycin, doxycycline, erythromycin, methicillin, moxifloxacin, kanamycin, telithromycin, rifampicin, methicillin-resistant, vancomycin-intermediate Staphylococcus aureus subsp. aureus Mu50 assessed as concentration required for partial growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1539,734245,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as concentration required for partial growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1540,734246,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1541,734249,1,2,,103219982,3220,Unspecified,,,,,Cytotoxicity against mouse BALB/3T3 cells assessed as growth inhibition after 48 hrs by Alamar blue assay,Other,23534483.0,
1542,734250,1,3,,103219982,3220,Unspecified,,,,,Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by Alamar blue assay,Other,23534483.0,
1543,734251,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against ceftazidime, ciprofloxacin, cefepime, gentamycin, imipenem, meropenem, piperacillin/tazobactam-resistant Pseudomonas aeruginosa 63230 assessed as growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1544,734252,1,2,,103219982,3220,Unspecified,,,,,Antibacterial activity against doxycycline-intermediate Streptococcus pyogenes 014327 assessed as growth inhibition by CLSI broth microdilution method,Other,23534483.0,
1545,734253,1,2,,103219982,3220,Unspecified,,,,,"Antibacterial activity against ceftazidime, clarithromycin, ciprofloxacin, clindamycin, doxycycline, erythromycin, methicillin, moxifloxacin, kanamycin, telithromycin, rifampicin, methicillin-resistant, vancomycin-intermediate Staphylococcus aureus subsp. aureus Mu50 assessed as growth inhibition by CLSI broth microdilution method",Other,23534483.0,
1546,743012,3,1,,144210197,3220,Inconclusive,,,0.0042,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1547,743012,3,1,,144213535,3220,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1548,743014,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1549,743014,3,1,,144213535,3220,Active,,,38.5708,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1550,743015,3,1,,144210197,3220,Active,,,1.6837,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1551,743015,3,1,,144213535,3220,Active,,,3.0638,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1552,743033,3,1,,144210197,3220,Active,,,12.0238,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1553,743033,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1554,743035,2,1,,144210197,3220,Active,124375976.0,367.0,26.9178,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1555,743035,2,1,,144213535,3220,Inconclusive,124375976.0,367.0,4.3647,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1556,743036,2,1,,144210197,3220,Inconclusive,124375976.0,367.0,10.7162,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1557,743036,2,1,,144213535,3220,Inconclusive,124375976.0,367.0,10.9635,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1558,743040,3,1,,144210197,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1559,743040,3,1,,144213535,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1560,743041,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1561,743041,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1562,743042,3,1,,144210197,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1563,743042,3,1,,144213535,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1564,743053,2,1,,144210197,3220,Inconclusive,124375976.0,367.0,9.01655,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1565,743053,2,1,,144213535,3220,Inconclusive,124375976.0,367.0,8.70863,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1566,743054,2,1,,144210197,3220,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1567,743054,2,1,,144213535,3220,Inconclusive,124375976.0,367.0,3.43762,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1568,743063,2,1,,144210197,3220,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1569,743063,2,1,,144213535,3220,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1570,743064,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1571,743064,3,1,,144213535,3220,Active,,,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1572,743065,3,1,,144210197,3220,Active,399498506.0,24831.0,23.7825,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1573,743065,3,1,,144213535,3220,Active,399498506.0,24831.0,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1574,743066,3,1,,144210197,3220,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1575,743066,3,1,,144213535,3220,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1576,743067,2,1,,144210197,3220,Inconclusive,399498506.0,24831.0,11.9195,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1577,743067,2,1,,144213535,3220,Inconclusive,399498506.0,24831.0,12.1972,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1578,743069,2,1,,144210197,3220,Inactive,348019627.0,2099.0,8.5122,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1579,743069,2,1,,144213535,3220,Inactive,348019627.0,2099.0,6.9175,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1580,743074,2,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1581,743074,2,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1582,743075,2,1,,144210197,3220,Active,348019627.0,2099.0,6.0262,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1583,743075,2,1,,144213535,3220,Active,348019627.0,2099.0,7.7616,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1584,743077,2,1,,144210197,3220,Active,348019627.0,2099.0,7.59203,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1585,743077,2,1,,144213535,3220,Active,348019627.0,2099.0,10.9649,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1586,743078,2,1,,144210197,3220,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1587,743078,2,1,,144213535,3220,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1588,743079,3,1,,144210197,3220,Active,348019627.0,2099.0,5.3242,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1589,743079,3,1,,144213535,3220,Active,348019627.0,2099.0,1.7229,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1590,743080,3,1,,144210197,3220,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1591,743080,3,1,,144213535,3220,Inconclusive,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1592,743081,3,1,,144210197,3220,Active,,,29.9404,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1593,743081,3,1,,144213535,3220,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1594,743083,3,1,,144210197,3220,Active,119597822.0,1588.0,23.7825,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1595,743083,3,1,,144213535,3220,Active,119597822.0,1588.0,54.4827,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1596,743084,3,1,,144210197,3220,Active,,,11.9195,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1597,743084,3,1,,144213535,3220,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1598,743085,3,1,,144210197,3220,Active,51095037.0,196.0,5.9739,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1599,743085,3,1,,144213535,3220,Active,51095037.0,196.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1600,743086,3,1,,144210197,3220,Inconclusive,,,3.3594,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1601,743086,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1602,743091,2,1,,144210197,3220,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1603,743091,2,1,,144213535,3220,Inconclusive,348019627.0,2099.0,61.1306,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1604,743094,3,1,,144210197,3220,Inconclusive,216409692.0,5468.0,8.5122,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1605,743094,3,1,,144213535,3220,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1606,743122,2,1,,144210197,3220,Active,51095037.0,196.0,8.43835,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1607,743122,2,1,,144213535,3220,Active,51095037.0,196.0,14.2208,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1608,743126,1,1,,56322653,3220,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1609,743139,2,1,,144210197,3220,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1610,743139,2,1,,144213535,3220,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1611,743140,2,1,,144210197,3220,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1612,743140,2,1,,144213535,3220,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1613,743191,3,1,,144210197,3220,Inconclusive,216409692.0,5468.0,2.3991,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1614,743191,3,1,,144213535,3220,Inconclusive,216409692.0,5468.0,43.6465,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1615,743194,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1616,743194,3,1,,144213535,3220,Inconclusive,,,10.9635,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1617,743199,2,1,,144210197,3220,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1618,743199,2,1,,144213535,3220,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1619,743202,4,1,,144210197,3220,Active,20149576.0,4780.0,4.2292,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1620,743202,4,1,,144213535,3220,Inconclusive,20149576.0,4780.0,9.6885,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1621,743203,3,1,,144210197,3220,Active,,,23.7825,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1622,743203,3,1,,144213535,3220,Inconclusive,,,76.9588,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1623,743205,1,1,,90340961,3220,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1624,743205,1,1,,90340961,3220,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1625,743206,1,1,,90340961,3220,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1626,743206,1,1,,90340961,3220,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1627,743207,1,1,,90340961,3220,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1628,743207,1,1,,90340961,3220,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1629,743209,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1630,743209,3,1,,144213535,3220,Inconclusive,,,24.5442,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1631,743210,4,1,,144210197,3220,Inconclusive,4504517.0,3315.0,26.9178,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1632,743210,4,1,,144213535,3220,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1633,743211,3,1,,144210197,3220,Inconclusive,,,30.2023,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1634,743211,3,1,,144213535,3220,Inconclusive,,,10.9635,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1635,743212,3,1,,144210197,3220,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1636,743212,3,1,,144213535,3220,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1637,743213,3,1,,144210197,3220,Inconclusive,,,26.9178,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1638,743213,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1639,743215,3,1,,144210197,3220,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1640,743215,3,1,,144213535,3220,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1641,743217,3,1,,144210197,3220,Inconclusive,325495553.0,9971.0,26.9178,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1642,743217,3,1,,144213535,3220,Inconclusive,325495553.0,9971.0,17.375999999999998,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1643,743218,3,1,,144210197,3220,Inconclusive,,,30.2023,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1644,743218,3,1,,144213535,3220,Inconclusive,,,5.4948,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1645,743219,3,1,,144210197,3220,Inconclusive,20149576.0,4780.0,4.22919,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1646,743219,3,1,,144213535,3220,Active,20149576.0,4780.0,10.4614,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1647,743220,3,1,,144210197,3220,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1648,743220,3,1,,144213535,3220,Inconclusive,325495553.0,9971.0,34.6697,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1649,743221,3,1,,144210197,3220,Inconclusive,,,26.9178,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1650,743221,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1651,743222,3,1,,144210197,3220,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1652,743222,3,1,,144213535,3220,Inconclusive,216409708.0,7421.0,34.6697,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1653,743223,3,1,,144210197,3220,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1654,743223,3,1,,144213535,3220,Inconclusive,216409708.0,7421.0,4.8972,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1655,743224,3,1,,144210197,3220,Active,,,23.9906,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1656,743224,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1657,743225,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1658,743225,3,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1659,743226,2,1,,144210197,3220,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1660,743226,2,1,,144213535,3220,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1661,743227,2,1,,144210197,3220,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1662,743227,2,1,,144213535,3220,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1663,743228,3,1,,144210197,3220,Inconclusive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1664,743228,3,1,,144213535,3220,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1665,743238,1,1,,56322653,3220,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1666,743239,2,1,,144210197,3220,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1667,743239,2,1,,144213535,3220,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1668,743240,2,1,,144210197,3220,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1669,743240,2,1,,144213535,3220,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1670,743241,2,1,,144210197,3220,Inconclusive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1671,743241,2,1,,144213535,3220,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1672,743242,2,1,,144210197,3220,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1673,743242,2,1,,144213535,3220,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1674,743244,1,1,,90340961,3220,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1675,743247,1,2,,56322653,3220,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1676,743255,1,1,,47193718,3220,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1677,743266,1,2,,47193718,3220,Inactive,296080761.0,5745.0,19.9526,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1678,743269,1,1,,56322653,3220,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1679,743269,1,1,,56322653,3220,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1680,743279,1,2,,47193718,3220,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1681,743288,1,1,,17389019,3220,Active,,,44.6684,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1682,743288,1,1,,26753048,3220,Inconclusive,,,44.6684,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1683,743292,1,1,,17389019,3220,Active,,,31.6228,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1684,743292,1,1,,26753048,3220,Inconclusive,,,44.6684,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1685,743344,1,1,,174006698,3220,Inactive,,,21.1177,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1686,743345,1,1,,174006698,3220,Inactive,,,5.3045,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1687,743346,1,1,,174006698,3220,Inactive,,,14.9502,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
1688,743347,1,1,,174006698,3220,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1689,743397,1,1,,56322653,3220,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1690,743398,1,1,,56322653,3220,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1691,748704,1,1,,103219982,3220,Active,,,,,Induction of tau K19 (unknown origin) disaggregation assessed as decrease in paired helical filament formation measured disassembly-inducing half maxima after 10 days by thioflavin S fluorescence assay in presence of heparin,Other,23484434.0,
1692,748708,1,1,,103219982,3220,Active,,,1.1,IC50,Inhibition of tau K19 (unknown origin) aggregation assessed as inhibition of paired helical filament formation after 10 days by thioflavin S fluorescence assay in presence of heparin,Confirmatory,23484434.0,
1693,755271,1,2,,103219982,3220,Unspecified,,,,,Cytotoxicity against rat HBZY-1 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay,Other,23683594.0,
1694,755272,1,1,,103219982,3220,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced fibronectin production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
1695,755273,1,1,,103219982,3220,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced collagen-4 production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
1696,755276,1,1,,103219982,3220,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced IL-6 production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
1697,757709,1,1,,103219982,3220,Active,,,0.58,IC50,Inhibition of human recombinant CK2 expressed in Escherichia coli BL21(DE3) using RRRDDDSDDD as substrate after 15 mins by capillary electrophoretic analysis,Confirmatory,23711832.0,
1698,757712,1,1,,103219982,3220,Unspecified,,,,,Inhibition of human recombinant CK2 expressed in Escherichia coli BL21(DE3) using RRRDDDSDDD as substrate at 10 uM after 15 mins by capillary electrophoretic analysis relative to control,Other,23711832.0,
1699,977599,1,1,,103219982,3220,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1700,977602,1,2,,103219982,3220,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1701,977608,3,1,,46391843,3220,Active,14488739.0,,1.0,IC50,Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB,Other,10882732.0,
1702,977610,3,1,,208012229,3220,Active,,,1.85,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,12816539.0,
1703,977611,3,1,,170482260,3220,Active,254574814.0,,0.45,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,19433000.0,
1704,977611,3,1,,170482260,3220,Active,254574815.0,,0.45,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,19433000.0,
1705,1053175,2,1,,178126954,3220,Inactive,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
1706,1053197,1,1,,56322653,3220,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1707,1079960,1,1,,103219982,3220,Unspecified,,,,,Toxicity against Trichoplusia ni (cabbage looper) third-instar larvae stage assessed as mortality at 10 ug/ml for 24 hr by topical application,Other,23731643.0,
1708,1079962,1,1,,103219982,3220,Unspecified,,,,,Antifeedant activity against Trichoplusia ni (cabbage looper) third-instar larvae stage assessed as feeding deterrence index at 50 microg/cm'2 by feeding deterrent bioassay,Other,23731643.0,
1709,1080756,1,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Botryotinia fuckeliana as inhibition of mycelium growth after 4 days,Other,19650641.0,
1710,1080758,1,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Botryotinia fuckeliana assessed as growth inhibition at 500 ug/mL after 4 days,Other,19650641.0,
1711,1080759,1,1,,103219982,3220,Active,,,46.3,IC50,Antibacterial activity against Staphylococcus aureus after 24 hr by agar disk diffusion method,Confirmatory,19650641.0,
1712,1080760,1,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Rhizoctonia solani assessed as growth inhibition at 500 ug/mL after 2 days,Other,19650641.0,
1713,1080765,1,1,,103219982,3220,Unspecified,,,,,Antibacterial activity against Bacillus cereus using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
1714,1080766,1,1,,103219982,3220,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
1715,1080767,1,1,,103219982,3220,Unspecified,,,,,Antibacterial activity against Escherichia coli using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
1716,1080768,1,1,,103219982,3220,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa using 50 uL of compound solution from 500 ug/mL stock solution after 24 hr by agar disk diffusion method,Other,19650641.0,
1717,1083211,3,1,,103219982,3220,Inactive,,,,,Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay,Other,23163769.0,
1718,1084062,1,2,,103219982,3220,Unspecified,,,,,Inhibition of alpha-glucoamylase (unknown origin) assessed as 1-Ki/Kc X 100% at 100 mg/l after 10 min spectrophotometry,Other,,
1719,1084069,1,2,,103219982,3220,Unspecified,,,,,Inhibition of alpha-glucoamylase (unknown origin) assessed as Ki/Kc at 100 mg/l after 10 min spectrophotometry,Other,,
1720,1098732,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed by dual choice leaf disc bioassay,Other,,
1721,1098733,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed at 1 ug/cm'2 by dual choice leaf disc bioassay (Rvb = 53 +/- 2.44 to 53.6 +/- 2.61 cm'2),Other,,
1722,1098734,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed at 5 ug/cm'2 by dual choice leaf disc bioassay (Rvb = 52.6 +/- 1.34 to 55.6 +/- 3.71 cm'2),Other,,
1723,1098735,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Spodoptera litura in Ricinus communis leaves assessed as mean leaf area fed at 10 ug/cm'2 by dual choice leaf disc bioassay (Rvb = 52.8 +/- 2.50 to 53.6 +/- 4.76 cm'2),Other,,
1724,1098736,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed by dual choice leaf disk bioassay,Other,,
1725,1098737,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed at 1 ug/cm'2 by dual choice leaf disk bioassay (Rvb = 0.75 +/- 0.06 to 0.92 +/- 0.05 cm'2),Other,,
1726,1098738,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed at 5 ug/cm'2 by dual choice leaf disk bioassay (Rvb = 0.74 +/- 0.02 to 0.91 +/- 0.01 cm'2),Other,,
1727,1098739,1,2,,103219982,3220,Unspecified,,,,,Antifeedant activity against Henosepilachna vigintioctopunctata in Solanum nigrum leaves assessed as mean leaf area fed at 10 ug/cm'2 by dual choice leaf disk bioassay (Rvb = 0.78 +/- 0.04 to 0.99 +/- 0.17 cm'2),Other,,
1728,1102423,1,1,,103219982,3220,Inactive,,,,,Antifungal activity against Botryotinia fuckeliana assessed as inhibition of conidia germination at 1 to 10 ug/mL after 5 hr by light adverse phase microscopic analysis,Other,12903946.0,
1729,1102424,3,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Verticillium dahliae assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
1730,1102425,3,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Sclerotinia sclerotiorum assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
1731,1102426,3,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Sclerotinia minor assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
1732,1102427,3,1,,103219982,3220,Unspecified,,,,,Antifungal activity against Botryotinia fuckeliana assessed as mycelial growth inhibition after 4 to 8 days,Other,12903946.0,
1733,1116651,1,2,,103219982,3220,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown on Lowenstein-Jensen solid medium assessed as growth inhibition incubated with compound dissolved in DMSO measured after 4 weeks,Other,,
1734,1116652,1,2,,103219982,3220,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown on Lowenstein-Jensen solid medium assessed as growth inhibition incubated with compound dissolved in water measured after 4 weeks,Other,,
1735,1155420,1,3,,103219982,3220,Active,59798989.0,28380388.0,17.1,IC50,Inhibition of AGR quorum sensing system in methicillin-resistant Staphylococcus aureus AH2759 incubated for 15 hrs by P3-LUX reporter gene assay,Confirmatory,24911880.0,
1736,1159509,1,1,,144210197,3220,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1737,1159509,1,1,,144213535,3220,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1738,1159515,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1739,1159515,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1740,1159516,1,1,,144210197,3220,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1741,1159516,1,1,,144213535,3220,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1742,1159517,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1743,1159517,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1744,1159518,1,1,,144210197,3220,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1745,1159518,1,1,,144213535,3220,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1746,1159519,1,1,,144210197,3220,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1747,1159519,1,1,,144213535,3220,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1748,1159520,1,1,,144210197,3220,Inconclusive,,,26.6844,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1749,1159520,1,1,,144213535,3220,Inconclusive,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1750,1159521,1,1,,144210197,3220,Inactive,15928672.0,19885.0,0.4229,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1751,1159521,1,1,,144213535,3220,Inconclusive,15928672.0,19885.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1752,1159523,1,1,,144210197,3220,Inconclusive,15928672.0,19885.0,11.9195,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1753,1159523,1,1,,144213535,3220,Inconclusive,15928672.0,19885.0,61.1306,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1754,1159524,1,1,,47193718,3220,Inconclusive,,,39.8107,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1755,1159525,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1756,1159525,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1757,1159526,1,1,,144210197,3220,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1758,1159526,1,1,,144213535,3220,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1759,1159527,1,1,,144210197,3220,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1760,1159527,1,1,,144213535,3220,Inconclusive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1761,1159528,1,1,,144210197,3220,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1762,1159528,1,1,,144213535,3220,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1763,1159529,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1764,1159529,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1765,1159531,1,1,,144210197,3220,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1766,1159531,1,1,,144213535,3220,Inconclusive,325495497.0,6256.0,17.375999999999998,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1767,1159550,3,1,,252401331,3220,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1768,1159551,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1769,1159551,1,1,,144213535,3220,Inconclusive,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1770,1159552,1,1,,144210197,3220,Inactive,325495463.0,5914.0,23.7825,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1771,1159552,1,1,,144213535,3220,Inactive,325495463.0,5914.0,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1772,1159553,2,1,,144210197,3220,Active,325495463.0,5914.0,9.468,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1773,1159553,2,1,,144213535,3220,Inconclusive,325495463.0,5914.0,3.0638,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1774,1159555,1,1,,144210197,3220,Inconclusive,325495463.0,5914.0,19.6302,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1775,1159555,1,1,,144213535,3220,Inconclusive,325495463.0,5914.0,6.60073,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1776,1159580,2,1,,268738163,3220,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1777,1159580,2,1,,273003103,3220,Active,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1778,1159583,2,1,,178126954,3220,Inactive,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
1779,1159606,1,1,,56322653,3220,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1780,1159607,2,1,,313042046,3220,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1781,1164704,1,1,,103219982,3220,Unspecified,,,317.4,IC50,Cytotoxicity against human MCF7 cells after 48 hrs by PrestoBlue cell viability assay,Confirmatory,25226568.0,
1782,1167184,1,1,,103219982,3220,Unspecified,,,,,Inhibition of human recombinant CK2a1/CK2b holoenzyme expressed in Escherichia coli BL21(DE3) at 10 uM pre-incubated for 10 mins before substrate addition by capillary electrophoresis based assay,Other,25272055.0,
1783,1167185,1,1,,103219982,3220,Active,,,0.58,IC50,Inhibition of human recombinant CK2a1/CK2b holoenzyme expressed in Escherichia coli BL21(DE3) pre-incubated for 10 mins before substrate addition by capillary electrophoresis based assay,Confirmatory,25272055.0,
1784,1202638,1,2,,103219982,3220,Active,125266.0,1459.0,2.0,IC50,Inhibition of CK2 (unknown origin),Confirmatory,25912672.0,
1785,1202638,1,2,,103219982,3220,Active,54037520.0,1460.0,2.0,IC50,Inhibition of CK2 (unknown origin),Confirmatory,25912672.0,
1786,1202638,1,2,,103219982,3220,Active,55977123.0,1457.0,2.0,IC50,Inhibition of CK2 (unknown origin),Confirmatory,25912672.0,
1787,1224818,1,1,,312344677,3220,Inconclusive,,,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
1788,1224819,1,1,,312344677,3220,Inconclusive,325495545.0,2101.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1789,1224820,1,1,,312344677,3220,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1790,1224821,1,1,,312344677,3220,Inactive,325495545.0,2101.0,2.6603,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1791,1224822,1,1,,312344677,3220,Inconclusive,,,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
1792,1224823,1,1,,312344677,3220,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1793,1224824,1,1,,174006698,3220,Inactive,,,10.4904,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
1794,1224825,1,1,,174006698,3220,Inactive,,,20.930999999999997,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
1795,1224834,3,1,,144210197,3220,Inconclusive,,,33.5937,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1796,1224834,3,1,,144213535,3220,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1797,1224835,1,1,,144210197,3220,Active,160794.0,,34.7788,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1798,1224835,1,1,,144213535,3220,Active,160794.0,,31.7055,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1799,1224836,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1800,1224836,1,1,,144213535,3220,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1801,1224837,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1802,1224837,1,1,,144213535,3220,Inconclusive,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1803,1224838,1,1,,144210197,3220,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1804,1224838,1,1,,144213535,3220,Inactive,66775687.0,9970.0,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1805,1224839,1,1,,144210197,3220,Inconclusive,66775687.0,9970.0,33.5937,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1806,1224839,1,1,,144213535,3220,Active,66775687.0,9970.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1807,1224840,3,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1808,1224840,3,1,,144213535,3220,Inconclusive,,,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1809,1224841,3,1,,144210197,3220,Inactive,325495545.0,2101.0,5.9739,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1810,1224841,3,1,,144213535,3220,Inconclusive,325495545.0,2101.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1811,1224842,3,1,,144210197,3220,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1812,1224842,3,1,,144213535,3220,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1813,1224843,1,1,,144210197,3220,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1814,1224843,1,1,,144213535,3220,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1815,1224844,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1816,1224844,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1817,1224845,1,1,,144210197,3220,Inconclusive,344243002.0,100757539.0,43.9831,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1818,1224845,1,1,,144213535,3220,Inconclusive,344243002.0,100757539.0,50.4772,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1819,1224846,1,1,,144210197,3220,Inconclusive,11995455.0,3091.0,10.7162,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1820,1224846,1,1,,144213535,3220,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1821,1224847,1,1,,144210197,3220,Active,,,55.3715,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1822,1224847,1,1,,144213535,3220,Active,,,80.0009,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1823,1224848,3,1,,144210197,3220,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1824,1224848,3,1,,144213535,3220,Active,325495545.0,2101.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1825,1224849,3,1,,144210197,3220,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1826,1224849,3,1,,144213535,3220,Inactive,325495545.0,2101.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1827,1224852,2,1,,90340961,3220,Inactive,,,,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human neural progenitor cells (hNPCs),Confirmatory,,
1828,1224853,2,1,,90340961,3220,Active,,,4.8859,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1829,1224854,2,1,,90340961,3220,Inactive,,,,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytoma cells,Confirmatory,,
1830,1224855,2,1,,90340961,3220,Active,,,1.9451,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1831,1224856,2,1,,90340961,3220,Inactive,,,,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytes,Confirmatory,,
1832,1224857,2,1,,174006698,3220,Active,,,9.3495,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1833,1224857,2,1,,312344677,3220,Active,,,2.5119,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1834,1224858,2,1,,90340961,3220,Active,,,2.7475,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytes,Confirmatory,,
1835,1224859,2,1,,90340961,3220,Inconclusive,,,6.3096,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1836,1224859,2,1,,174006698,3220,Active,,,9.3495,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1837,1224860,2,1,,90340961,3220,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1838,1224861,2,1,,90340961,3220,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytes,Confirmatory,,
1839,1224862,2,1,,90340961,3220,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytoma cell line (SNB-19),Confirmatory,,
1840,1224865,1,2,,56322653,3220,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1841,1224867,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1842,1224867,1,1,,144213535,3220,Inconclusive,,,48.9722,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1843,1224868,1,1,,144210197,3220,Inconclusive,,,21.3816,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1844,1224868,1,1,,144213535,3220,Inconclusive,,,38.9,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1845,1224869,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1846,1224869,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1847,1224870,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1848,1224870,1,1,,144213535,3220,Inconclusive,,,48.9722,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1849,1224871,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1850,1224871,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1851,1224872,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1852,1224872,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1853,1224873,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1854,1224873,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1855,1224874,1,1,,144210197,3220,Inconclusive,,,21.3816,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1856,1224874,1,1,,144213535,3220,Inconclusive,,,43.6465,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1857,1224875,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1858,1224875,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1859,1224876,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1860,1224876,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1861,1224877,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1862,1224877,1,1,,144213535,3220,Inconclusive,,,48.9722,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1863,1224878,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1864,1224878,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1865,1224879,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1866,1224879,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1867,1224880,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1868,1224880,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1869,1224881,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1870,1224881,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1871,1224882,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1872,1224882,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1873,1224883,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1874,1224883,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1875,1224884,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1876,1224884,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1877,1224885,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1878,1224885,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1879,1224886,1,1,,144210197,3220,Inconclusive,,,21.3816,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1880,1224886,1,1,,144213535,3220,Inconclusive,,,38.9,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1881,1224887,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1882,1224887,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1883,1224888,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1884,1224888,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1885,1224889,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1886,1224889,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1887,1224890,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1888,1224890,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1889,1224892,1,1,,144210197,3220,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1890,1224892,1,1,,144213535,3220,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1891,1224893,1,1,,144210197,3220,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1892,1224893,1,1,,144213535,3220,Inconclusive,66775687.0,9970.0,33.082,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1893,1224894,1,1,,144210197,3220,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1894,1224894,1,1,,144213535,3220,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1895,1224895,1,1,,144210197,3220,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1896,1224895,1,1,,144213535,3220,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1897,1224896,1,1,,144210197,3220,Inconclusive,344243002.0,100757539.0,55.3715,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1898,1224896,1,1,,144213535,3220,Inconclusive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1899,1224905,2,1,,121361429,3220,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1900,1224905,2,1,,121361429,3220,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1901,1256630,1,1,,103219982,3220,Unspecified,67476665.0,2053.0,,,Inhibition of sEH (unknown origin) assessed as 6-methoxy-2-naphthaldehyde formation at 50 uM by fluorometry assay using 40 uM cyano-(6-methoxy-naphthalen-2-yl)-methyl ester as substrate,Other,26483136.0,
1902,1256631,1,1,,103219982,3220,Unspecified,67476665.0,2053.0,,IC50,Inhibition of sEH (unknown origin) assessed as 6-methoxy-2-naphthaldehyde formation by fluorometry assay using 40 uM cyano-(6-methoxy-naphthalen-2-yl)-methyl ester as substrate,Confirmatory,26483136.0,
1903,1259241,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1904,1259241,1,1,,144213535,3220,Active,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1905,1259242,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1906,1259242,1,1,,144213535,3220,Active,,,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1907,1259243,1,1,,144210197,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1908,1259243,1,1,,144213535,3220,Active,124375976.0,367.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1909,1259244,1,1,,144210197,3220,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1910,1259244,1,1,,144213535,3220,Active,348019627.0,2099.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1911,1259247,1,1,,144210197,3220,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1912,1259247,1,1,,144213535,3220,Inconclusive,124375976.0,367.0,58.82899999999999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1913,1259248,1,1,,144210197,3220,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1914,1259248,1,1,,144213535,3220,Inconclusive,348019627.0,2099.0,37.1186,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1915,1259252,1,1,,174006698,3220,Inconclusive,169655958.0,,29.5659,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
1916,1259253,1,1,,174006698,3220,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
1917,1259255,1,1,,174006698,3220,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
1918,1259256,1,1,,174006698,3220,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
1919,1259309,1,1,,178126954,3220,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
1920,1259310,1,1,,332949666,3220,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1921,1259310,1,1,,332949715,3220,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1922,1259311,1,1,,178126954,3220,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
1923,1259313,1,1,,47193718,3220,Active,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1924,1259318,1,1,,56322653,3220,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1925,1259354,1,1,,348424633,3220,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
1926,1259364,1,1,,144210197,3220,Active,1013403374.0,9734.0,5.3242,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1927,1259364,1,1,,144213535,3220,Active,1013403374.0,9734.0,1.9331,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1928,1259365,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1929,1259365,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1930,1259366,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1931,1259366,1,1,,144213535,3220,Inconclusive,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1932,1259367,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1933,1259367,1,1,,144213535,3220,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1934,1259368,1,1,,144210197,3220,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1935,1259368,1,1,,144213535,3220,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1936,1259369,1,1,,144210197,3220,Inconclusive,109731339.0,2737.0,33.5937,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1937,1259369,1,1,,144213535,3220,Active,109731339.0,2737.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1938,1259370,2,2,,124633118,3220,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1939,1259370,2,2,,124633118,3220,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1940,1259370,2,2,,124633118,3220,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1941,1259377,1,1,,144210197,3220,Inconclusive,54288833.0,2100.0,29.9404,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1942,1259377,1,1,,144213535,3220,Active,54288833.0,2100.0,4.8558,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1943,1259378,1,1,,144210197,3220,Inconclusive,54288833.0,2100.0,13.3739,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1944,1259378,1,1,,144213535,3220,Inconclusive,54288833.0,2100.0,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1945,1259379,1,1,,144210197,3220,Active,,,26.6844,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1946,1259379,1,1,,144213535,3220,Active,,,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1947,1259380,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1948,1259380,1,1,,144213535,3220,Inconclusive,,,13.6854,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1949,1259381,1,1,,144210197,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1950,1259381,1,1,,144213535,3220,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1951,1259382,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1952,1259382,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1953,1259383,1,1,,144210197,3220,Active,348019627.0,2099.0,11.9195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1954,1259383,1,1,,144213535,3220,Active,348019627.0,2099.0,6.859,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1955,1259384,1,1,,144210197,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1956,1259384,1,1,,144213535,3220,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1957,1259385,1,1,,144210197,3220,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1958,1259385,1,1,,144213535,3220,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1959,1259386,1,1,,144210197,3220,Inconclusive,,,1.6837,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1960,1259386,1,1,,144213535,3220,Active,,,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1961,1259387,1,1,,144210197,3220,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1962,1259387,1,1,,144213535,3220,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1963,1259388,1,1,,144210197,3220,Active,1013403374.0,9734.0,4.56658,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1964,1259388,1,1,,144213535,3220,Active,1013403374.0,9734.0,1.86034,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1965,1259389,1,1,,124633118,3220,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1966,1259390,1,1,,144210197,3220,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1967,1259390,1,1,,144213535,3220,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1968,1259391,1,1,,144210197,3220,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1969,1259391,1,1,,144213535,3220,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1970,1259392,1,1,,144210197,3220,Inconclusive,109731339.0,2737.0,16.8367,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1971,1259392,1,1,,144213535,3220,Inconclusive,109731339.0,2737.0,34.3762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1972,1259393,1,1,,144210197,3220,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1973,1259393,1,1,,144213535,3220,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1974,1259394,1,1,,144210197,3220,Active,54288833.0,2100.0,13.3739,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1975,1259394,1,1,,144213535,3220,Active,54288833.0,2100.0,4.85577,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1976,1259395,1,1,,144210197,3220,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1977,1259395,1,1,,144213535,3220,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1978,1259396,1,1,,144210197,3220,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1979,1259396,1,1,,144213535,3220,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1980,1259401,1,1,,144210197,3220,Inconclusive,325495545.0,2101.0,5.97389,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1981,1259401,1,1,,144213535,3220,Inconclusive,325495545.0,2101.0,63.5221,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1982,1259402,1,1,,144210197,3220,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1983,1259402,1,1,,144213535,3220,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1984,1259403,1,1,,144210197,3220,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1985,1259403,1,1,,144213535,3220,Inconclusive,325495545.0,2101.0,54.4827,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1986,1259404,1,1,,144210197,3220,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1987,1259404,1,1,,144213535,3220,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1988,1259407,1,1,,363901478,3220,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1989,1259408,1,1,,363895675,3220,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
1990,1259411,1,1,,363901478,3220,Unspecified,,,,,CCRIS carcinogenicity studies,Other,,
1991,1259415,1,1,,56322653,3220,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
1992,1259416,1,2,,340085825,3220,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1993,1259421,1,1,,340085825,3220,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1994,1259423,1,2,,354753344,3220,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
